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Qualitative and quantitative analyses of target biomolecules in the cell are essential for 
the early detection of diseases and the prognosis of treatment in various biomedical research 
and clinical applications. To selectively detect and quantify biomolecules of interest in 
complicated biological samples, various methods have been developed in the biotechnology 
fields. Target biomolecules in the cells can be specifically visualized with labeling probes by 
fluorescent cell imaging and quantified with immunoassay based on antigen-antibody 
interactions.  
 
The aim of the thesis is to develop the functional protein-based target-specific labeling 
nanoplatforms for application in fluorescent cell imaging and immunoassays. Target 
biomolecules within the cell can be detected with target-specific fluorescent cell imaging 
probes. Protein cage nanoparticles as attractive polyvalent nanoplatforms have been applied to 
bioimaging probes and biosensor components because they have a well-defined symmetric 
hollow shell structure with uniform nanoscale particle sizes. Their polyvalent nature allows 
uniform multiple targeting ligands or fluorescent probes to genetically and/or chemically 
adhere to their surface. A new class of protein cage nanoparticles, encapsulin, was developed 
as a tunable dual-functional nanoplatform, which has its target-specific capability with multiple 
combinations of targeting ligands and colors, using bacterial glue, the SpyTag/SpyCatcher 
(ST/SC) protein ligation system.  
 
Next, target-specific signal amplifiers were developed as secondary antibody mimics to 
be applied in immunoassays. Immunoassays are utilized to selectively detect and quantify low-
abundance biomolecules in biological samples through antigen-antibody interaction. HRP-
conjugated IgG-binding nanobodies were established using ST/SC protein ligation system. 
They have selective and strong binding to specific IgG and show signal amplifying capability 
in various types of immunoassays, such as western blot, ELISA, and the multiplex TSA cell 
and tissue imaging.  
 
A variety of target-specific labeling probes demonstrated that they could be utilized in 
fluorescent cell imaging and immunoassays by combining fluorescent molecules or signal 
generating enzyme with targeting ligands, including affibody molecules or nanobodies.  
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Chapter 1. Introduction 
 
1.1. Qualitative and Quantitative Analyses of Target Biomolecules in Cells  
Cells have various expression level of proteins, which play important roles in cell structure, 
regulation of metabolism and cell to cell communication in cellular life. Therefore, qualitative and 
quantitative analyses of target proteins in cell are essential to understand molecular and cellular 
processes within living system. Various techniques have been developed in biomedical research and 
clinical applications to selectively visualize and quantify target proteins of interest in complex 
biological samples. 
 
1.1.1 Visualization of Target Biomolecules 
Fluorescence cell imaging is useful method to selectively detect and visualize cell components and 
morphology as well as to investigate cellular behaviors and responses derived from internal and/or 
external stimuli within biological complex. Fluorescence is produced by target proteins or fluorophore 
conjugated to target proteins and is excited and emitted at certain wavelength. Therefore, this method 
requires detectable fluorescent probes, which usually are labeled around the target proteins. Three kinds 
of labeling probes will be described here. 
 
Target-Specific Fluorescent probes  
Fluorescent probes are useful tools for fluorescent cell imaging due to their sensitivity and 
versatility while minimizing perturbation of target cells (Figure 1.1).1-3 Typically, fluorescent probes 
consist of fluorophores, which have no specificity for the target protein. For clinical applications, most 
fluorescent probes are combined with targeting moiety for targeting efficiency. Frist, many cancer-
specific fluorescent probes have been established by targeting cancer cell markers such as growth 
signaling receptors, angiogenesis growth factors, and tumor cell markers. Current strategies for cancer 
targeting probes are established by incorporating imaging agents with cancer-specific ligands by 
chemical conjugation or genetic insertion. Cancer targeting probes recognize cancer sites and bind to 
specific molecular targets. Becker, et al. reported serum protein-dye conjugates consisting of transferrin 
or human serum albumin and an indotricarbocyanine (ICG) derivates for the optical imaging of breast 
cancer.4 Ogawa, et al. demonstrated the breast cancer targeting probes by combining IcG with 
monoclonal antibodies directed at cell surface markers overexpressed on breast cancers.5 There are 
target-specific fluorescent probes by combining fluorescent dye and biomolecules-targeting peptide as 
well as cancer. Wei, et al. suggested fluorescent peptide probes by combining collagen targeting peptide 
with the repetitive Gly-Pro-Pro and Gly-Hyp-Hyp sequences, and fluorescent dye, 5(6)-
carboxyfluorescein (FAM).6 Even though these strategies have many advantages such as high 
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fluorescence intensity and specificity to targets, they still need chemical modification to conjugate 
fluorophore, which may induce heterogeneity with high manufacturing costs and a long preparation 
time. Recently, target-specific fluorescent probes are generated by combining biocompatible 
nanomaterials with targeting ligands, including antibody, affibody molecules, or nanobody. They can 
recognize specific biomolecules in target cells with enhanced stability, reduced toxicity, and improved 
targeting efficiency.  
 
Figure 1.1 Overview of fluorescent probes. (A) Non-specific small fluorescent molecules, (B) 
fluorescent agents conjugated to antibodies, (C) targeted peptides, or (D) molecular beacon.7 
 
Self-labeling Tag Systems 
In self-labeling tag system, genetically encoded tags with targeting specificity can be fused to 
target proteins, which are recognized by cognate ligand and catalyzed for covalent attachment.8 HaloTag, 
SNAP-Tag, and CLIP-Tag are representative self-labeling tags, which are used for protein purification, 
cellular imaging, and protein-protein interaction analysis.9-12 These tags possess several advantages; 
rapid labeling kinetics, high labeling intensity, and thermal stability. Each tag is expressed with the 
target proteins in the cell, and covalently conjugated with specific ligands conjugated to a fluorescent 
dye (Figure 1.2). Many of these ligands have produced with cell-permeable property across cellular 
membranes allowing for live cell labeling and imaging analysis. Los, et al. demonstrated the utility of 
HaloTag system for cellular imaging and protein immobilization by analyzing multiple molecular 
processes associated with NF-κB-mediated cellular physiology, including imaging of subcellular 
protein translocation and capture of protein−protein and protein−DNA complexes.13 In Charubin’s 
group, they used HaloTag and SNAP-tag to label the anaerobic organisms with fluorescent ligands 
commercially available.14 HaloTag can be utilized to study cellular signaling on the proteins regulating 
biological processes. However, they do not share fluorescent ligands and the appropriate ligand must 
be changed each time a specific tag is used. Also, the size of the protein tag is not small, which can 




Figure 1.2 Examples of self-labeling tag systems and applications in microscopy.8 
 
Visualization using Antibody-Antigen Interaction   
Immunofluorescence is commonly used for visualization of target proteins based on antibody-
antigen interaction. This method is preferred due to its high sensitivity and specificity toward its target. 
Generally, this method is based on two different antibodies – primary antibody and secondary antibody. 
The primary antibody binds to the target proteins itself or its epitope, followed by binding with 
fluorescent dye or enzyme conjugated secondary antibodies, which emit light at certain wavelength or 
reacts with the substrate to produce colored product, respectively (Figure 1.3A). Tyramide signal 
amplification (TSA) assay is one of the representative signal amplification methods for detecting low-
abundant target molecules in various type of biological samples.15, 16 In this assay, biotin- or 
fluorophore-conjugated tyramide is activated by peroxidase, which is conjugated to secondary antibody. 
Phenolic group of the tyramide is catalyzed with hydrogen peroxide, and generated reactive tyramide 





1.1.2 Quantitation of Target Biomolecules 
It is important to determine how much proteins exist in biological complex. That is measured as 
the concentration or the relative amount in quantity of proteins.  
 
Immunoassays 
Immunoassay is one of biochemical methods which use antibodies to detect the presence and 
concentration of target molecules in biological samples. The immunoassay is based on antigen-antibody 
interaction and utilize two different types of antibodies-primary antibody and secondary antibody. The 
purpose of primary antibody detects the target molecules with high binding affinity. The purpose of 
secondary antibody is to amplify the primary signal. Therefore, secondary antibodies are typically 
conjugated with signal amplifying enzymes such as horseradish peroxidases (HRP), which repeatedly 
convert inactive substrates to signal-generating active products.17, 18 HRP has various kinds of substrates 
such as 2,2' -azino-di-[3-ethylbenzthiazoline-6-sulfonic acid (ABTS), 3,3',5,5'-tetramethylbenzidine 
(TMB), which have been utilized in immunoassay, immunochemistry, and electro-analytical chemistry. 
As a result, they can generate considerable amplification of low primary signals in a concentration-
dependent manner. Amplified signals can be quantitatively detected via colorimetric, fluorescent, and 
chemiluminescent measurements (Figure 1.4). Therefore, low-abundance biomolecules in biological 
samples are selectively detected and quantified by immunoassays. 
 
Figure 1.3 Immunofluorescence using antibody-antigen interaction 
 
Figure 1.4 A example of immunoassay, enzyme-linked immunosorbent assay (ELISA) 
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1.2 Functional Proteins-based Nanoplatforms 
1.2.1 Protein cage nanoparticles 
A wide range of nanoparticles have been developed as nanoscale delivery templates including 
liposomes,19, 20 micelles,21, 22 inorganic and polymeric nanoparticles,23-27 and protein cage 
nanoparticles,28 for effective therapeutic and/or diagnostic reagents to the target sites in vitro/in vivo. 
Especially, protein cage nanoparticles, including virus-like particles,29, 30 P22 viral capsid,31, 32 and 
lumazine synthase,33 are derived from nature, and have well-controlled structure, biocompatibility and 
solubility (Figure 1.5). They have a symmetric protein structure and are made up of identical subunits 
with a highly uniform size distribution, and their atomic resolution crystal structures have been 
investigated. They are stable to chemical and genetic modifications of their surface. Therefore, the 
exterior surfaces of protein cage nanoparticles could be modified for presenting various types of 
molecules including affinity tags, antibodies, fluorophore, and targeting peptides. They have been 
utilized as polyvalent nanoplatforms for developing bioimaging probes and biosensor. 
Encapsulin protein cage nanoparticles (Encap) is isolated from thermophile Thermotoga 
maritima.34, 35 They are self-assembled from 60 copies of identical subunit in a precisely controlled 
manner. Encap is developed as effective nanocarriers of antigenic peptides and therapeutic and/or 
diagnostic reagents using protein engineering. The exterior surfaces of Encap is displayed with 
hepatocellular carcinoma (HCC) cell binding peptide (SP94-peptides, SFSIIHTPILPL) through genetic 
insertion. SP94-peptide displaying Encap effectively and selectively targeted HepG2 cells, and was 
detected by fluorescent microscopy imaging.34  
 
 
Figure 1.5 Surface diagram representations of various types of protein cage nanoparticles. (a) Ferritin 
(PDB:2JD6) (b) Lumazine synthase (PDB:1HQK) (c) Encapsuline (PDB:3DKT) (d) CCMV 




1.2.2 Monomeric proteins 
There are many types of monomeric proteins with their unique characteristics and functions 
(Figure 1.6). Recombinant fusion proteins could be genetically fused with two or more monomeric 
proteins by genetic engineering. They are applied in various biomedical research with high 
biocompatibility.  
 
Fluorescent proteins for cancer cell imaging 
Many fluorescent proteins were developed as reporter proteins to investigate protein localization 
and trafficking within the cells.37 They have many advantages for biological researches. They are 
relatively small proteins, which can be easily fused to target proteins and dose not interfere the function 
of target proteins. They are expressed without any toxicity in living cells. To visualize them, the light is 
only needed without the addition of exogenously added substrates. Green fluorescent protein (GFP) was 
first isolated form the jellyfish Aequorea victoria, and engineered to generate color mutants, such as 
blue fluorescent protein (BFP), cyan fluorescent protein (CFP), and yellow fluorescent proteins (YFP).   
 
Scaffold proteins as the templates for chemical conjugation 
Scaffold proteins play key roles in providing templates for chemical conjugation and complexation 
of them. Scaffold proteins have side chain to be covalently conjugated with chemical dye or ligands. 
Glutathione S-transferase (GST) has high affinity toward glutathione (GSH) and reactive cysteines 
which can form disulfide bonds with maleimide conjugated molecules through the maleimide – thiol 
reaction. On the other hand, scaffold proteins have a high affinity to its binder molecules. 
Monostreptavidin (mSA) has a high affinity for biotin and conjugates with biotinylated molecules. 
 
Enzymes for signal amplification assay 
Enzyme are proteins that accelerate chemical reactions with substrates. Heme peroxidases, such 
as ascorbate peroxidase-2 (APEX2), are well known as a powerful enzyme for proximity-labeling in 
biotechnology.38 It can generate reactive singlet oxygens to activate dye molecules to label surrounding 
proteins. Proteomic mapping in live Drosophila tissues was established using an engineered ascorbate 
peroxidase.39 Another useful enzyme is luciferase, which generates bright luminescence. Especially, 
nanoluciferase (Nanoluc) is a novel luciferase, which have enhanced stability, smaller size, and brighter 
luminescence intensity than other luciferases.40  
 
Affibody molecules for cancer cell targeting 
In the late 90s and early 2000, advances in protein engineering technology resulted in the 
development of several non-antibody protein scaffold formats. Affibody molecules are monomeric 
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proteins consisting of three helical domains with small size of about 6.5 kDa. They can recognize their 
target molecules with high binding affinity and selectivity.41-45 Since one of the first targets was HER2, 
which is overexpressed in the breast cancer cells,41 a variety of affibody molecules specific for target 
molecules have been generated by protein engineering. Compared to antibody, they have solubility and 
thermostability. They can also be produced in high yields in bacterial overexpression system, which 
means they can be genetically fused to any type of protein. These properties have contributed to 
promising antibody alternatives. Therefore, various recombinant fusion proteins with affibody have 
been applied in diagnostic and therapeutic studies.43   
 
Anti-IgG binding nanobody for primary antibody detection in signal amplification assay 
Nanobody is also known as a camelid or shark-derived single-domain antibody, which composed 
of a single monomeric variable antibody domain. It is smaller in size compared to original antibody and 
has the potential to be produced as recombinant fusion proteins.46-48 It has also binding affinity to a 
specific target molecule. In particular, anti-IgG binding nanobodies were produced by phage display 
selections. They have binding affinity toward all mouse IgG subclasses and rabbit IgG and can be used 
as secondary antibody alternatives.49     
  
 






1.2.3 Genetic Encoded Protein Tags 
SpyTag/SpyCatcher (ST/SC) protein ligation system 
Two different functional proteins can be physically linked by genetic engineering or post-
translational ligation. As one of the post-translational ligation system, SpyTag/SpyCatcher protein 
ligation system was introduced as protein bioconjugation system.50, 51 SpyTag/SpyCatcher pair is 
derived by splitting the immunoglobulin-like collagen adhesion domain, so-called CnaB2, of 
Streptococcus pyogenes. SpyTag and SpyCatcher are 13 amino acid (AHIVMVDAYKPTK) 
polypeptide fragments and 15 kDa, respectively, and they spontaneously form a covalent isopeptide 
bond between residues Lys31 and Asp117 upon their recognition (Figure 1.7A). Ligation is 
reconstituted under a wide range of pH values, temperuature, and in various detergents. SpyTag and 
SpyCatcher are reactive at the N-terminal, C-terminal and internal positions of a proteins. With this 
flexibility of SpyTag/SpyCathcer, SpyTag and SpyCatcher can be genetically fused to any type of 
protein and can be used in vitro and in vivo (Figure 1.7B). 
 
 
Figure 1.7 Cartoon of SpyTag/SpyCatcher protein ligation system. (A) Crystal structure of the SpyTag 




1.3 Research Outline 
1.3.1 Objective for the Thesis 
In present research, many kinds of research suggest strategies to detect and visualize target 
molecules selectively. There are representative techniques in biomedical research. Fluorescence cell 
imaging is applied to visualize target molecules. Immunoassay is used to detect and quantify target 
molecules. These techniques are based on various types of molecules, which are fluorescent probes, 
labeling tag, and antibody.  
The overall goal of this research thesis is to develop target-specific labeling nanoplatforms 
based on functional proteins for application in fluorescence cell imaging and immunoassay. 
Protein-based labeling systems are recombinant proteins, which require low manufacturing costs and 
short preparation time with the E.coli overexpression system. 
Lists of research project are followed: 
1) Development of a target-specific fluorescent probes for fluorescence cell imaging 
2) Development of a target-specific signal enhancer for immunoassays and TSA imaging. 
 
1.3.2 Outline of the Thesis 
The thesis begins with the introduction of the overall research in chapter 1. First of all, the 
importance of qualitative and quantitative analyses of target biomolecules in cells are explained. Next, 
various types of tools in current research were introduced for visualization or quantitation of target 
biomolecules. In addition, several advantages and application of functional proteins were discussed. 
With the objectives for the thesis, development of target-specific fluorescent probes for fluorescence 
cell imaging was described in chapter 2. Next, development of target-specific signal enhancer was 







Chapter 2. Target-specific Fluorescent Probes for Fluorescence Cell Imaging 
based on Protein Cage Nanoparticles 
 
2.1.  Summary 
Selective detection and effective visualization of specific target cells are essential but challenging. 
Fluorescence cell imagings with target-specific probes have been popularly utilized to visualize cell 
morphology and components and analyze cellular processes. Multi-displays of targeting ligands on a 
polyvalent single template could be applied as versatile multiplex fluorescent probes capable of 
individually visualizing two or more target cells without using separate individual probes. To implement 
this goal, one of protein cage nanoparticles, encapsulin, is used as a template and modified for dual 
targeting abtility by displaying two different affibody molecules post-translationally. Encapsulin self-
assembles in 60 identical subunits, forming a hollow and symmetric spherical structure of uniform size. 
SpyTag peptides were genetically fused to the surface of encapsulin, and a variety of proteins, such as 
fluorescent proteins and targeting affibody molecules, were genetically fused with SpyCatcher. 
Fluorescent proteins and affibody molecules were simultaneously labeled on a single encapsulin in a 
mixing-and-matching manner through bacterial superglue, SpyTag/SpyCatcher protein ligation system, 
post-translationally. We developed dual functional encapsulins as target-specific fluorescence cell 
imaging probes. We further established dual targeting protein cage nanoparticles by displaying two 
different affibodies onto encapsulin surface, which have been demonstrated to effectively recognize and 
bind to two individual targeting cells, visualizing them independently with selective colors on demand. 
 
2.2.  Introduction 
Fluorescence cell imaging is typically applied to detect and visualize cell morphology and 
components and study cellular behaviors and responses derived from internal and/or external stimuli 
within biological systems.52 To precisely monitor the behaviors of specific cells, it is necessary to 
selectively label them with specific fluorescent probes. A wide range of target-specific fluorescent 
probes have been generated by combining fluorescent molecules with targeting ligands, including 
antibodies,5 targeting peptides,53-55 or affibody molecules.41, 42, 56, 57 Among them, affibody molecules 
are genetically engineered antibody mimics, which show high specificity and affinity for their targets. 
Affibody molecules have been applied for a wide range of biotechnology and therapeutic development 
in biomedicine with proven potential.42, 58-62 A combinatorial display of two or more affibody molecules 
on polyvalent platforms would allow for a dual or multiple targeting capabilities because each affibody 
molecule specifically recognizes and binds to its target cell. Protein cage nanoparticles are attractive 
polyvalent nanoplatforms for developing nanoscale bioimaging probes and biosensor components 
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because they have a well-defined symmetric hollow shell structure with uniform nanoscale particle sizes 
consisting of biomaterials, proteins.30, 63 They self-assemble in multiple copies of one or a few types of 
protein subunits in a precisely controlled manner. Their polyvalent characteristic often results in 
attachment of uniform multiple small ligands or chemicals to their surface genetically and/or chemically. 
Encapsulin (Encap) is a recently developed protein cage nanoparticle isolated from the thermophilic 
bacteria Thermotoga maritima.64, 65 We have previously developed Encaps as effective nanocarriers of 
antigenic peptides and therapeutic and/or diagnostic reagents using protein engineering.34, 66, 67 We have 
demonstrated that their genetic and chemical plasticity allows the simultaneous introduction of various 
oligopeptides genetically and diagnostic agents chemically at designated sites. Therefore, a single 
Encap can be given multiple functionalities simultaneously, such as targeting and probing 
functionalities. However, the genetic fusion of functional proteins onto protein cage nanoparticles often 
leads to misfolding of functional proteins and/or damage of self-assembly, and the chemical attachment 
of functional proteins to protein cage nanoparticles is only limited to tiny protein partners, and it is 
difficult to control their number and position.68, 69 
To circumvent these limitations, a recently developed bacterial superglue, the SpyTag/SpyCatcher 
(ST/SC) protein ligation system, was introduced in this research.50 The protein ligation system 
covalently links two individually purified functional proteins together post-translationally by 
recognizing 15 kDa SC and 13 amino acid ST, which   are genetically fused to corresponding partner 
proteins. SC and ST spontaneously form an irreversible isopeptide covalent bond upon recognition, and 
they can be genetically fused to any protein individually without a significant functional alteration of 
the fused proteins.70, 71 
In the current study, ST was genetically fused to the Encap surface loop region to construct tunable 
nanoplatforms and simultaneously displayed multiple types of SC-fused functional proteins, either 
fluorescent proteins and affibody molecules or two different affibody molecules, in a mixing-and-
matching manner (Figure 2.1). Using these tunable dual-functional Encap, we successfully 
demonstrated the targeting capability of dual-functional Encap with multiple combinations of targeting 
ligands and colors and the detecting ability of two different target cells with a single dual targeting 
Encap, which displays two different affibody molecules. Multiple display of functional proteins to 
polyvalent Encap was established using ST/SC in various ways on demand. These multiple functional 




Figure 2.1 Schematic illustration of target-specific fluorescent probes. Functional proteins were 
multivalently displayed on Encapsulin post-translationally using bacterial glue to establish multiplex 
fluroescent cell imaging toolkits .  
 
2.3. Materials and Methods 
Genetic manipulation and purification of SC-fusion monomeric proteins and ST inserted Encap 
SpyCatcher protein with extra amino acids was genetically fused to the C-termini of fluorescent 
proteins, mApple and eYFP (fluorescent proteins-SC), and N-termini of affibody molecules, HER2 and 
EGFR affibody molecules(SC-Afb), using established polymerase chain reaction (PCR) protocol with 
pETDuet based plasmids as a template.70 The residues AHIVMVDAYKPTK with extra amino acids 
were genetically inserted between residues 138 and 139 (loop region) of encapsulin subunit by PCR 
with pET-30b based plasmids containing genes encoding encapsulin, which has only one exterior 
cysteine per subunit at position 123, as a template.34 The amplified DNAs are transformed into 
competent E. coli strain BL21 (DE3), and the proteins were overexpressed. The E. coli cells containing 
resultant proteins were pelleted from 1.0 L of culture and were resuspended in 30 mL of phosphate 
buffer (50 mM sodium phosphate and 100 mM sodium chloride, pH 6.5). Lysozyme was added, and the 
solution was incubated for 30 min at 4°C. The suspension was sonicated for 10 min in 30 s intervals 
and subsequently centrifuged at 13000 g for 1 h at 4°C. SC fused monomeric proteins (fluorescent 
proteins-SC and SC-Afb) were purified with immobilized metal affinity chromatography (IMAC, 5 mL 
HisTrap FF column, GE HealthCare). SpyTag inserted encapsulin (Encap-L-ST) was purified with size 




Chemical conjugation of fluorescent dyes to Encap-L-ST 
Thiol-reactive fluorescent dyes, such as fluorescein 5-maleimide (Thermo Scientific, 62245) and 
Alexa fluor 546 C5 maleimide (Thermo Scientific, A10258), were conjugated to Encap-L-ST, which 
has one outer cysteine per subunit.73 Encap-L-ST was incubated with 5 mol equivalents of fluorescent 
dyes at room temperature with gentle shaking overnight. Free dyes were removed by dialysis with 
phosphate buffered saline (PBS) buffer overnight. The degree of fluorescent dye conjugation to Encap-
L-ST was determined with UV/Vis spectrophotometer and ESI-TOF mass spectrometer. For mass 
analyses, each fluorescein-conjugated Encap (fEncap-L-ST and aEncap-L-ST) samples were loaded 
onto a MassPREP microdesalting column (Waters) and eluted with a gradient of 5-95% (v/v) acetonitrile 
containing 0.1% formic acid at a flow rate of 500 μL/min. 
    
Ligations of SC-proteins and Encap-L-ST 
Concentrations of purified SC-proteins and Encap-L-ST were determined with either BCA assay 
or UV/Vis spectrophotometer. They were simply mixed with desired molar ratios and incubated for 
indicated time periods at room temperature with gentle shaking. Reaction resultants were analyzed with 
SDS-PAGE after adding SDS loading buffer and boiling at 110 ºC. Ligations of SC-proteins and Encap-
L-ST were further confirmed by measuring molecular masses of monomeric SC-Affibody molecules 
(SC-HER2Afb and SC-EGFRAfb) and reaction resultants (Encap:HER2Afb and Encap:EGFRAfb) 
with ESI-TOF mass spectrometer as described above. To characterize Encap protein cage architecture 
after ligations of SC-proteins, Encap ligated with a single type of SC-protein (Encap:HER2Afb, 
Encap:EGFRAfb, Encap:mApple and Encap:eYFP) and Encap with two different types of proteins 
(Encap:mApple:HER2Afb, Encap:mApple:EGFRAfb, Encap:eYFP:HER2Afb, and 
Encap:eYFP:EGFRAfb) were measured with size exclusion chromatography (SEC), dynamic light 
scattering (DLS), and transmission electron microscopy (TEM) analyses with the control sample.74        
 
Cell culture  
SK-BR-3 was cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
(v/v) fetal bovine serum (FBS) and 1% antibiotic-antimycotic. MCF-10A was cultured in DMEM/F12 
(1:1) supplemented with 5% horse serum, 1% penicillin-streptomycin, hEGF (100ug/mL), 
hydrocortisone (1mg/mL) and insulin (10mg/mL). MDA-MB-468 was cultured in Leibovitz’s L-15 
medium with 10% (v/v) FBS, 1% antibiotic-antimycotic, 25mM HEPES and NaHCO3. MCF-7 cells 
were cultured in RPMI-1640 supplemented with 5% FBS and 1% antibiotic-antimycotic. SK-BR-3, 
MCF-10A, MDA-MB-468 and MCF-7 cells were incubated in humidified atmosphere of 5% CO2 and 





Fluorescent cell microscopic imaging 
The cells (1 × 105/well) were grown on microscope cover glass (18 mm Φ) in 12-well plate (SPL, 
30012). Cells were fixed with 4% paraformaldehyde in PBS for 1 h and washed three times with PBS. 
To prevent non-specific binding of sample to the background, the blocking reagent (5% BSA, 5% FBS, 
and 0.5% Triton X-100 in PBS) was treated and incubated at room temperature for 1 h prior to sample 
treatment. After washing fixed cells three times with wash buffer (0.1% Triton X-100 in PBS), SC-
ligated Encaps were added and they were incubated for 1 h at room temperature. Encaps without 
affibody molecules were also added separately as negative controls under the same condition. Before 
sealing, the cells were washed three times with wash buffer, and nuclei were stained with 4’, 6-
diamidino-2-phenylindole (DAPI). Images of samples were obtained by using Olympus Fluoview 
FV1000 fluorescent microscope (Olympus, UOBC). 
   
2.4. Results and Discussion 
ST Inserted Encap (Encap-L-ST) and SC-Fused Affibody molecules (SC-Afb) were constructed. 
To polyvalently display affibody molecules as targeting ligands onto the Encap surface, we applied 
an ST/SC system.50 A short and unfolded ST peptide (AHIVMVDAYKPTK) was genetically inserted 
into the surface loop region (at the position between subunit residues 138 and 139) of Encap-L-ST with 
extra residues (GGGGGASASAS & ASASASGGGGG) on both sides of each ST to provide 
conformational flexibility and to guarantee full access of their counterparts, SC-fused proteins. In the 
previously report, the loop regions are tolerable for peptide insertion of various lengths. As they are 
exposed on the Encap surface, they are accessible to other molecules.34, 67 On the other hand, SC is 
genetically fused to two different affibody molecules, EGFRAfb and HER2Afb, which selectively 
recognize and bind to epidermal growth factor receptor (SC-EGFRAfb) and human epidermal growth 
factor receptor-2 (SC-HER2Afb) on the surface of specific cancer cells, respectively.70 SC-HER2Afb 
and SC-EGFRAfb were overexpressed in bacteria, purified with affinity chromatography, and their 
molecular masses were verified by an electrospray ionization time-of-flight mass spectrometer (ESI-
TOF MS). The molecular masses of SC-HER2Afb and SC-EGFRAfb were measured at 21863.5 Da 
and 21704.0 Da, which correspond to the calculated molecular masses of each protein, 21864.6 Da and 
21703.6 Da, respectively (Figure 2.2). Encap-L-ST has an external cysteine per subunit (60 cysteines 
per cage), and fluorescein-5-maleimide (F5M) was conjugated by a thiol-maleimide reaction and used 
as a fluorescent probe for fluorescent microscopic cell imaging.75 Fluorescein conjugated Encap-L-ST 
(fEncap-L-ST) was examined by a mass spectrometer and a UV/Vis spectrophotometer. The molecular 
mass of the F5M treated Encap-L-ST subunit was measured at 33831.0 Da, which corresponds well to 
the sum (33833.2 Da) of the calculated Encap-L-ST subunit molecular masses (33405.8 Da) and F5M 
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(427.4 Da) (Figure 2.3). To quantify the molar ratio between the Encap subunit and F5M, a standard 
curve from the absorbance of different concentrations of free F5M molecules was acquired and the 
absorbance of fEncap-L-ST at 280 nm and 490 nm was measured, which represented the concentrations 
of the Encap subunit and F5M, respectively. The obtained molar concentrations translated to 
approximately 98% Encap subunits labeled with fluoresceins (Figure 2.3), indicating that almost every 
Encap-L-ST subunit was labeled with fluorescein. 
 
Polyvalent fluorescently labeled Encap was ligated with affibody molecules using an ST/SC for target 
specific binding ability. 
To investigate whether genetically fused SC-EGFRAfb or SC-HER2Afb can covalently attach to 
the surface of fEncap-L-ST through an SC/ST isopeptide bond formation, ST and SC were simply mixed 
and sampled at indicated times (Figure 2.4). Initially, either SC-EGFRAfb or SC-HER2Afb was mixed 
with fEncap-L-ST with the subunit ratio of 1:2 to consume all of the introduced SC-Afb (SC-EGFRAfb 
or SC-HER2Afb) and to avoid steric hindrance among ligated affibody molecules. A sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analyses of those reactions showed that the 
ligation between SC-Afb and fEncap-L-ST took almost 6 h to be completed (Figure 2.4), whereas that 
of monomeric SC-fused and ST-fused proteins was completed almost within 5 min in previous reports.70, 
76 Previous studies suggested that the reactive aspartic acid of SC needs to be specifically aligned to 
facilitate ST with SC docking and to complete isopeptide formation24. Therefore, the sheet formation 
of ST in the Encap loop region may be hindered and delayed quite a bit due to a steric constraint in the 
loop. ESI-TOF mass spectrometric analyses were performed to confirm isopeptide formation between 
SC and ST further. The molecular masses of the resulting ligation reactions were measured at 55678.0 
Da (fEncap:HER2Afb) and 55516.5 Da (fEncap:EGFRAfb), respectively, which corresponded well to 
the calculated values of 55680.8 Da [21865.6 Da (SC-HER2Afb) + 33833.2 Da (fEncap-L-ST)–18 Da 
(H2O)] and 55517.8 Da [21703.6 Da (SC-EGFRAfb) + 33833.2 Da (fEncap-L-ST)–18 Da (H2O)] 
(Figure 2.2).  
To evaluate the specific binding of each affibody molecule-ligated fEncap toward its target cells, 
we prepared two cancer cell lines, MDA-MB-468 and SK-BR-3 cells, which overexpressed EGFR and 
HER2 on their surfaces, respectively. We treated MDA-MB-468 and SK-BR-3 cells with 
fEncap:EGFRAfb and fEncap:HER2, respectively, and with fEncap-L-ST in parallel as negative 
controls and monitored them using fluorescent microscopy. Each ligated complex bound to their target 
cells efficiently (Figure 2.5, middle panels), whereas fEncap-L-ST without affibody molecules did not 
bind to either cell lines (Figure 2.5, top panels). Affibody molecule-ligated fEncap also did not bind to 
MCF-10A or MCF-7 cells, which do not overexpress HER2 and EGFR on their surfaces, respectively, 
(Figure 2.5, bottom panels), suggesting that fEncap-L-ST itself and the affibody molecule-ligated 
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fEncap do not bind to non-targeted cells significantly. These data indicated that polyvalently displayed 
affibody to Encaps effectively recognize their target cancer cells and selectively visualize them without 
any significant non-specific binding. 
 
Figure 2.2 Molecular mass measurements of two different SC-Afbs. (a) SC-HER2Afb or (b) SC-
EGFRAfb, and a subunit of reaction resultants of fEncap-L-ST and (c) SC-HER2Afb or (d) SC-
EGFRAfb. Calculated and observed molecular masses are indicated. 
 
 
Figure 2.3 Characterization of fEncap-L-ST. (a) Molecular mass measurements of a subunit of 
Encap-L-ST (top) and fEncap-L-ST (bottom). Calculated and observed molecular masses are indicated. 







Figure 2.4 SDS-PAGE analyses of reaction results of SC-Afb and fEncap-L-ST. ST/SC ligation of  
(a) SC-HER2Afb and fEncap-L-ST and (b) SC-EGFRAfb and fEncap-L-ST was sampled at the 
indicated times, run on SDS-PAGE, and stained with Coomassie blue. Molecular weight markers were 
run together, and the apparent molecular weights are indicated (solid arrow indicates SC-Afb molecule-







Figure 2.5 Fluorescent microscopic images with affibody molecule-ligated fEncap-L-ST. Various 
cancer cell lines are treated with (a) fEncap:HER2Afb and (b) fEncap:EGFRAfb. Cell lines and affibody 
molecules (with or without) are indicated on the left of the image panels. Nuclei are stained with DAPI 





Multiple functional proteins were effectively displayed on the surface of Encap by ST/SC. 
To investigate whether two different functional proteins can be displayed on the surface of Encap-
L-ST, we selected two different fluorescent proteins, mApple and eYFP, as fluorescent probes. SC was 
genetically fused to the C-termini of fluorescent proteins mApple (mApple-SC) or eYFP (eYFP-SC) 
with extra amino acids as a linker. We previously demonstrated that SC-fused monomeric proteins could 
be easily ligated with ST-fused monomeric proteins.70 To display both fluorescent proteins and affibody 
molecules simultaneously on the surface of Encap, we simply mixed the same amount of fluorescent 
protein-SC (mApple-SC or eYFP-SC) with the SC-Affibody molecule (SC-HER2Afb or SC-EGFRAfb) 
in a mixing-and-matching manner with Encap-L-ST. There are four combinations of multiple functional 
protein ligated Encap (Encap:mApple:HER2Afb, Encap:mApple:EGFRAfb, Encap:eYFP:HER2Afb, 
and Encap:eYFP:EGFRAfb, respectively). We performed size exclusion chromatography (SEC), 
dynamic light scattering, and transmission electron microscopy (TEM) analyses for characterization of 
functional protein ligated Encap. Encap ligated with a single protein type (Encap:HER2Afb, 
Encap:EGFRAfb, Encap:mApple and Encap:eYFP) or with two different types of proteins 
(Encap:mApple:HER2Afb, Encap:mApple:EGFRAfb, Encap:eYFP:HER2Afb and 
Encap:eYFP:EGFRAfb) were eluted slightly earlier than Encap-L-ST in SEC (Figure 2.6a), and their 
hydrodynamic diameters (36.68, 35.26, 39.12, 38.15, 42.26, 40.86, 38.69, and 41.50 nm, respectively) 
were also correspondingly larger than that of Encap-L-ST (32.59 nm) (Figure 2.6b). TEM images of 
negatively-stained SC-protein-ligated Encap confirmed their intact cage architecture and smudged extra 
densities at the exterior area, indicating that SC-proteins were well displayed on the Encap surface 
(Figure 2.6c). These results indicate that simultaneous ligations of fluorescent protein-SC and SC-Afb 
onto the surface of Encap-L-ST at defined ratios do not cause any significant alteration to the Encap 
protein cage architecture. To evaluate the tolerance of ligation amounts of SC-proteins to the surface of 
Encap-L-ST, we tested three different input ratios of SC-proteins to subunits of Encap-L-ST; 1:1:6 [10 
fluorescent protein-SCs and 10 SC-affibody molecules per an Encap-L-ST (60 subunits per cage)] 
(Figure 2.7a, 2.7d, 2.7g, and 2.7j, Encap:mApple:HER2Afb, Encap:eYFP:HER2Afb, 
Encap:mApple:EGFRAfb, and Encap:eYFP:EGFRAfb, respectively), 2:2:6 (Figure 2.7b, 2.7e, 2.7h, 
and 2.7k), or 3:3:6 (Figure 2.7c, 2.7f, 2.7i, and 2.7l) and estimated the degree of covalent conjugations 
among them with SDS-PAGE (Figure 2.7). Most of the added SC-proteins were covalently attached to 
Encap-L-ST. However, reactions of 3:3:6 generated a noticeable amount of protein aggregation, 
probably due to the steric hindrance of ligated SC-proteins on the Encap surface. To avoid this 
aggregation issue but maximize functionality, we hereafter used the reaction results of 2:2:6 (Figure 2.8) 
for further studies. These data showed the maintenance of their integrity and function after the ST/SC 
ligation and approximately 20 affibody molecules and 20 fluorescent proteins per Encap can be 










Figure 2.6 Characterizations of SC-proteins ligated Encap. (a) Size exclusion elution 







Figure 2.7 Optimization of input ratio of SC-proteins to subunit of Encap using SDS-PAGE. (a, d, 
g and j) 1:1:6 [10 fluorescent protein-SC and 10 SC-Afb molecule per an Encap-L-ST (60 subunits per 
cage), Encap:mApple:HER2Afb, Encap:eYFP:HER2Afb, Encap:mApple:EGFRAfb, and 
Encap:eYFP:EGFRAfb, respectively], (b, e, h and k) 2:2:6 (c, f, i and l) 3:3:6. Solid arrow indicates 
fluorescent protein-SC ligated Encap (Encap:mApple or Encap:eYFP). Blank arrow indicated SC-Afb 
molecule ligated Encap (Encap:HER2Afb or Encap:EGFRAfb). Reactions were sampled at indicated 
times, run on SDS-PAGE, and stained with Coomassie blue. Molecular weight markers were run 




Figure 2.8 SDS-PAGE analyses of reaction results of SC-proteins and Encap. ST/SC ligation of (a) 
Encap:mApple:HER2Afb, (b) Encap:eYFP:HER2Afb, (c) Encap:mApple:EGFRAfb, and (d) 
Encap:eYFP:EGFRAfb. The input ratio of SC-protein to Encap is 2:2:6 [20 fluorescent protein-SC and 
20 SC-affibody per Encap-L-ST (60 subunits per cage)]. Reactants were sampled at the indicated times, 
run on SDS-PAGE, and stained with Coomassie blue. Molecular weight markers were run together, and 
the apparent molecular weights are indicated (solid arrow indicates fluorescent protein-SC-ligated 
Encap (Encap:mApple or Encap:eYFP); blank arrow indicated SC-Afb molecule ligated Encap 




Dual functional Encap showed specific binding to their target cancer cells. 
To evaluate the capability of targeted cell imaging of dual-functional Encap, we prepared two 
different target cancer cells, MDA-MA-468 and SK-BR-3, and treated four different combinations of 
dual-functional Encap (Encap:mApple:HER2Afb, Encap:eYFP:HER2Afb, Encap:eYFP:EGFRAfb, 
and Encap:eYFP:EGFRAfb) to them for fluorescence microscopic cell imaging, as previously described. 
SC-HER2Afb ligated dual functional Encap (Encap:mApple:HER2Afb and Encap:eYFP:HER2Afb) 
selectively bound to SK-BR-3 cells with red and yellow colors, respectively. Similarly, dual-functional 
Encaps with SC-EGFRAfb (Encap:mApple:EGFRAfb and Encap:eYFP:EGFRAfb) also selectively 
bound to their target, MDA-MB-468 cells, with corresponding fluorescent colors (Figure 2.9), whereas 
Encap without affibodies did not bind to target cancer cells, consistent with previous results (Figure 
2.5). Furthermore, neither of the dual functional Encaps bound to HER2 negative MCF 7 cells or EGFR 
negative MCF 10A cells. These data indicate simultaneous targeting and visualizing with dual 
functional Encap with multiple combinations between desired targeting ligands and desired colors. This 
approach provides the opportunity for various Encap functionalities by ST/SC protein ligation on 
demand. 
 
Figure 2.9 Fluorescent microscopic images of with dual functional Encap. Various cancer cell lines 
are treated with (a) Encap:mApple:HER2Afb, (b) Encap:eYFP:HER2Afb, (c) 
Encap:mApple:EGFRAfb, and (d) Encap:eYFP:EGFRAfb. Cell lines and affibody molecules used are 
indicated on the left of the image panels. Nuclei are stained with DAPI (blue, left panels). mApple and 




Two different targeting ligands ligated Encap was applied for dual targeting imaging. 
Two different affibody molecules were polyvalently displayed to fluorescent dye-labeled Encap-
L-ST. Before dual targeting imaging to give a dual-targeting capability to a single Encap probe. We 
checked the possibility of cross-targeting among affibody molecule-ligated Encap. First, we prepared 
either green fluorescent dye, F5M, or red fluorescent dye, Alexa flour 546 maleimide to construct 
fluorescently labeled Encap-L-STs (fEncap-L-ST and aEncap-L-ST). Encap-L-ST was labeled with 
Alexa fluor 546 maleimide, and all Encap-L-ST subunits were also labeled with an Alexa fluor 546 
maleimide (Figure 2.10), the same as those of F5M. fEncap-L-ST and aEncap-L-ST were subsequently 
ligated with SC-HER2Afb and SC-EGFRAfb, respectively, to form fEncap:HER2Afb and 
aEncap:EGFRAfb (Figure 2.11a). To check the cross-targeting possibility of fEncap:HER2Afb and 
aEncap:EGFRAfb, we treated SK-BR-3 and MDA-MB-468 cells with fEncap:HER2Afb and 
aEncap:EGFRAfb (Figure 2.12a and 2.12b), respectively, or aEncap:EGFRAfb and fEncap:HER2Afb 
(Figure 2.12c and 2.12d), respectively. As expected, green fluorescence only appeared in 
fEncap:HER2Afb-treated SK-BR-3 cells targeted by HER2Afb (Figure 2.12a), and red only appeared 
in aEncap:EGFRAfb-treated MDA-MB-468 cells, which are targeted by EGFRAfb (Figure 2.12b). 
These results imply that each affibody molecule-ligated Encap selectively recognizes its target cells and 
tightly binds them without any significant cross-targeting events. 
For multiplex cell imaging, we treated fluorescently labeled Encap-L-ST with two different SC-
Afbs (SC-HER2Afb and SC-EGFRAfb) to visualize two or more target cells (Figure 2.11b). Encap-L-
ST chemically conjugated with one type of fluorescent dye (fEncap or aEncap) was ligated with both 
SC-HER2Afb and SC-EGFRAfb simultaneously as a master key to open multiple locks (to visualize 
multiple target cells with a fluorescent probe) (fEncap:HER2Afb:EGFRAfb or 
aEncap:HER2AFb:EGFRAfb). Each target cell was detected by the color corresponding to the labeled 
dye (Figure 2.12e and 2.12f) compared with the negative control cell line, HEK293T (Figure 2.13). 
Together, these results suggest that Encap-L-ST can serve as a multivalent template by efficiently 
displaying two or more different targeting ligands and can be used to detect two or more target cells 






Figure 2.10 Characterization of aEncap-L-ST. (a) Molecular mass measurements of a subunit of 
Encap-L-ST (top) and aEncap-L-ST (bottom). Calculated and observed molecular masses are indicated. 





Figure 2.11 Characterization of reaction products for fluorescent microscopic images using SDS-
PAGE. Solid arrows indicate (a) fEncap:HER2Afb for Figure 2.12a and 2.12c (left) and 
aEncap:EGFRAfb for Figure 2.12b and 2.12d (right). (b) fEncap:HER2Afb:EGFRAfb and 







Figure 2.12. Fluorescent microscopic images with dual targeting Encap. Various cancer cell lines 
are treated with (a) fEncap:HER2Afb, (b) aEncap:EGFRAfb, (c) aEncap:EGFRAfb, (d) 
fEncap:HER2Afb (e and f) fEncap:HER2Afb:EGFRAfb (top), and aEncap:HER2AFb:EGFRAfb 
(bottom). Cell lines, affibody molecules, and fluorescently-labeled Encap are indicated on the left of 
the image panels. Nuclei are stained with DAPI (blue, left panels). Fluoresceins are visualized in green 






Figure 2.13. Fluorescent microscopic images of HEK293T cells treated with dual targeting 
Encap. Affibodies and fluorescein labeled Encap are indicated on the left of image panels. Nuclei are 






Here, a tunable dual-functional (targeting and probing or two different targetings) Encap protein 
cage nanoparticle was established using bacterial superglue, ST/SC, and its target-specific imaging 
capability was demonstrated with multiple combinations of targeting ligands and colors. Encap surface 
with symmetric cage structrue was displayed with ST peptides polyvalently by genetic engineering. On 
the other hand, various fluorescent proteins and affibody molecules were genetically fused to SC-
protein and prepared independently. SC-fused fluorescent proteins (mApple-SC or eYFP-SC) and 
affibody molecules (SC-EGFRAfb or SC-HER2Afb) were simultaneously displayed on the Encap-L-
ST surface via a covalent isopeptide formation between ST and SC, and they were successfully 
demonstrated as combinatorial target-specific fluorescent probes. Dual targeting Encap probes were 
further constructed by displaying two different affibody molecules on their surface, and they visualized 
two target cells individually without using a set of individual probes. The polyvalent nature of Encap 
allowed us to display multiple functional proteins efficiently, and ST/SC bacterial glue made it possible 
to post-translationally display the desired functional proteins in a mixing-and-matching manner on 
demand. The approach we described here can be applied to other protein cage nanoparticles, protein 
oligomers, protein binding partners, and other functional proteins and may provide new opportunities 
to develop novel multifunctional delivery nanoplatforms and multifunctional complementary nanoscale 




Chapter 3. Target-specific Signal Amplifiers for Immunoassays 
 
3.1 Summary 
Commercial secondary antibodies for immunoassays are usually produced by live animals or 
expensive mammalian cell culture systems. These antibodies are then conjugated with enzymes that 
amplify low-abundant target molecules’ signal in a concentration-dependent manner, which repeatedly 
converts inactive substrates to signal-generating active products. In this study, we developed 
recombinant immunoglobulin G (IgG)-binding nanobody-based signal amplifiers using a well-
established SpyTag/SpyCatcher protein ligation system. SpyCatcher as a scaffold protein was 
chemically conjugated with activated horseradish peroxidase (HRP), and SpyTag was genetically fused 
to two IgG-binding nanobodies specific for the Fc regions of mouse IgG1 and rabbit IgG, which is 
denoted as MG1Nb and RNb, respectively. We selectively ligated HRP-conjugated SpyCatcher with 
SpyTag-fused MG1Nb or RNb depending on the original species of primary antibodies and enhanced 
target molecules’ signals in a plug-and-playable manner. We successfully demonstrated that 
HRP:MG1Nb and HRP:RNb selectively bind to target-bound mouse IgG1 or rabbit IgG, respectively, 
and perform as excellent target-specific signal amplifiers in various immunoassays such as western blot, 
enzyme-linked immunosorbent assay (ELISA), and multiplex tyramide signal amplification (TSA) cell 
and tissue imaging. These recombinant signal-amplifying IgG-binders can be simple and reliable 
alternatives to conventional secondary antibodies in various immunoassays. 
 
3.2 Introduction 
Qualitative and quantitative analysis of target biomolecules in cell, blood, and tissue samples are 
essential for early disease detection and prognosis of treatment in various biomedical research and 
clinical applications.77-79 Immunoassay is a biochemical methods that utilize antibodies to detect the 
presence and concentration of specific target molecules in biological component mixtures.80 The 
immunoassay is based on antigen-antibody interaction and employs two different types of antibodies-
primary antibody and secondary antibody. The primary antibody detects the target molecules with a 
high binding affinity for target-specific recognition and selection, thus ensuring the accuracy and 
precision of the assay. However, the secondary antibody’s purpose is to recognize and bind to the target-
bound primary antibody, regardless of the target molecule. And then, they generate signals that high 
enough for detection. Secondary antibodies are generally conjugated with horseradish peroxidases 
(HRP), which repeatedly convert inactive substrates to signal-generating active products. As a result, 
they can generate considerable amplification of low primary signals in a concentration-dependent 
manner. Amplified signals can be quantified via colorimetric, fluorescent, and chemiluminescent 
measurements. Therefore, low-abundance biomolecules in biological samples are selectively detected 
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and quantified by immunoassays. Although enzyme-conjugated secondary antibodies are widely used 
for signal amplification, their production requires live animals or mammalian cell culture systems with 
high manufacturing costs, long preparation time, and animal welfare and ethical issues compared to 
recombinant protein production with bacterial overexpression systems. Therefore, there is a high 
demand for the development of immunoglobulin G (IgG)-binding recombinant signal amplifiers, which 
have primary antibody-binding ability and generate signals of significant intensities. 
We tried to develop IgG-binding recombinant signal amplifiers, we have previously introduced the 
antibody binding domain (ABD) derived from Staphylococcus aureus protein A as a universal non-
immunoglobulin IgG binder which has a high binding affinity to and specificity for the Fc region of 
various IgGs.38, 81 For signal amplification, we fused the ABD to glutathione-S-transferase (GST) to 
create a scaffolding protein for conjugation to multiple activated HRPs. The HRP-GST-ABD bound to 
the Fc region of target-bound primary antibodies derived from various species, and amplified target-
specific signals in both enzyme-linked immunosorbent assays (ELISA) and immunohistochemistry. 
However, HRP-GST-ABD lacked species-selectivity, binding to the Fc region of various IgGs 
regardless of the origin of the primary antibody.73 In a similar approach, Jeong et al. developed IgG 
binder molecules, repebody, composed of leucine-rich repeat modules and specific to IgG from different 
species, by phage display. Repebody was further labeled with various signal generators such as HRP, a 
fluorescent dye, and quantum dots for use in immunoassays and imaging as an alternative to 
conventional secondary antibodies.82 Meanwhile, single-domain antibodies, also known as nanobodies, 
are commonly used as scaffolding proteins to screen high affinity binders against specific target 
molecules for diagnostic and therapeutic purposes.47, 48, 83-85 Nanobodies derived from camelids or 
sharks are highly stable in a wide temperature range and easily used as recombinant fusion proteins 
with various functional proteins due to their small size and high stability in bacterial overexpression 
systems. Recently, anti-IgG nanobodies against various mouse IgG subclasses and rabbit IgGs were 
screened and generated by phage display. High quantities of these nanobodies were produced in 
bacterial overexpression systems and directly labeled with fluorophores or enzymes for signal 
enhancement in various immunoassays and immunostaining.49 
In this study, we prepared two species-specific IgG-binding nanobodies specific for Fc regions of 
mouse IgG1 and rabbit IgG, denoted as MG1Nb and RNb, respectively. To establish plug-and-playable 
modular IgG-binding signal amplifier, we used the well-established SpyTag/SpyCatcher protein ligation 
system, which allowed us to covalently ligate above two individual functional modules post-
translationally. Each MG1Nb and RNb were genetically fused with a SpyTag peptide and the activated 
HRP was chemically conjugated to SpyCatcher. HRP-conjugated SpyCatcher was efficiently ligated to 
each SpyTag-fused IgG-binding nanobody in a plug-and-playable manner. Target-specific signal 











3.3 Materials and Methods 
Genetic modification and purification of SpyCatcher-S10C and SpyTag fused nanobodies 
Serine residue at position 10 of SpyCatcher protein was substituted with cysteine using established 
polymerase chain reaction (PCR) protocol with pETDuet based plasmids as a template.71 TP1107 with 
an additional cysteine in pTP1112 and TP897 with three additional cysteines in pTP955 were gifts from 
Dirk Görlich (Addgene plasmids #104158 and #104164, respectively).49 SpyTag (AHIVMVDAYKPTK) 
was genetically inserted to the N-termini of anti-mouse IgG1 nanobody (TP1107) and anti-rabbit IgG 
nanobody (TP1897) with an extra flexible linker by PCR with pETDuet based plasmids as a template. 
Recombinant DNAs were transformed into competent E. coli strain BL21(DE3), and cells were grown 
in 1.0 L of Luria-Bertani (LB) medium containing 10 mg/L of ampicillin, induced with 0.5 mM of 
isopropyl β-D-1-thiogalactopyranoside (IPTG), and harvested by centrifugation at 13000 g. The E. coli 
cells containing resultant proteins were resuspended in 30 mL of lysis buffer (50 mM sodium phosphate, 
100 mM sodium chloride, and 15 mg/L of lysozyme, pH 7.4) and incubated for 30 min at 4°C. The 
suspension was sonicated for 10 min in 30 s intervals and subsequently centrifuged at 13000 g for 1 h 
at 4°C. Each protein was purified with batch type of Ni2+-NTA affinity chromatography.  
 
Chemical conjugation of horseradish peroxidase (HRP) or fluorescent dyes to SCS10C 
EZ-Link Maleimide Activated Horseradish Peroxidase (Mal-HRP, Thermo Fisher) was conjugated 
to SCS10C (HRP-SC). SCS10C was incubated with 5 mol equivalents of Mal-HRP at 4°C with gently 
shaking overnight. Unconjugated SCS10C and Mal-HRP were removed by using Ni2+-NTA affinity 
chromatography and centrifugal filter (Millipore, MWCO: 50 kDa) sequentially. Thiol-reactive 
fluorescent dyes such as fluorescein 5-maleimide (F5M) (Thermo Fisher) and Alexa fluor 647 C2 
maleimide (Invitrogen) were independently conjugated to SCS10C. SCS10C was incubated with 3 mol 
equivalents of fluorescent dyes at 4°C with gently shaking overnight. Free dyes were removed by 
centrifugal filter (Millipore, MWCO: 10 kDa). 
 
Construction of HRP:Nbs or fluorescent dye conjugated Nbs using SpyTag/SpyCatcher ligation  
For HRP:Nbs or fluorescent dye conjugated Nbs, HRP-SC, F5M-SC, Alexa647-SC and two 
different SpyTag fused nanobodies (MG1Nb-ST and RNb-ST) were mixed with the molar ratio of 1:1.5 
to use up all available HRP-SC, F5M-SC, or Alexa647-SC. They were incubated at indicated times (10, 
30 min, 1, 3, 6 h, and overnight) at room temperature with gentle shaking. Reaction resultants were 
analyzed with SDS-PAGE after adding SDS loading buffer and boiling at 110 ºC. We removed unligated 
free MG1Nb-ST or RNb-ST using centrifugal filter and quantitated the molar ratio between the HRP or 




Surface plasmon resonance (SPR) analysis 
SPR experiments were performed with carboxyl dextran CM5 gold chips on a Biacore 3000 device 
(Biacore AB, Sweden) at 25 °C using both HBS-EP buffer as an immobilization solution and PBS buffer 
as a running solution. Each mouse IgG1 or rabbit IgG was immobilized onto the surface of CM5 sensor 
chips by standard amine-coupling chemistry.86, 87 Briefly, a mixture of EDC (50 mg/ml) and NHS (50 
mg/ml) was injected onto the chip at a flow rate of 10 μL/min to activate carboxyl groups on the sensor 
chip surface and subsequently 0.1 mg/ml of mouse IgG1 or rabbit IgG were added into two different 
channels at the same flow rate. Excess reactive groups were blocked with 1 M ethanolamine (pH 8.0). 
Subsequently, MG1Nb-ST, RNb-ST, HRP:MG1Nb, or HRP:RNb (PBS, pH 7.4) were introduced with 
various concentration to monolayers of mouse IgG1 or rabbit IgG immobilized CM5 sensor chips at a 
flow rate of 10 μL/min. The associating and dissociating parameters of them to either mouse IgG1 or 
rabbit IgG were analyzed by fitting the SPR data with Biaevaluation software using the 1:1 Langmur 
binding model.88  
 
Western blot 
The concentration of purified FLAG-HaloTag protein and cell lysates of HEK293T transiently 
transfected with gene of FLAG-HaloTag were determined by BCA assay. Each diluted protein sample 
was denatured and separated on SDS-PAGE (Bio-Rad). The separated proteins were transferred from 
the gel to a polyvinylidene fluoride (PVDF) membranes using Bolt® Mini Blot Module (Invitrogen, 
20V, 1 h) and the membranes were blocked with 5% (w/v) skim milk in TBST for 1 h at RT. Anti-FLAG 
mouse IgG1 (Abcam) and anti-FLAG rabbit IgG (Thermo Fisher) were used as primary antibodies for 
selective detection. The blocked membranes were then incubated overnight at 4 °C with each diluted 
primary antibody according to manufacturer’s protocol. After three washes in TBST, membranes were 
incubated for 1 h at RT with anti-mouse or anti-rabbit HRP-conjugated secondary antibodies (Jackson 
ImmunoResearch Inc.) or HRP:Nbs (HRP:MG1Nb or HRP:RNb). The concentration of HRP:Nbs was 
determined by UV/vis photospectrometer and diluted to corresponding concentration of HRP-
conjugated secondary antibodies. After three washes in TBST, the membranes were further incubated 
with the enhanced chemiluminescence (ECL) western blotting substrate solutions (Thermo Fisher) for 
the purpose of the signal development and enhancement. 
 
Simple Indirect ELISA 
The experiments were conducted with transparent Immuno MicroWell 96-well plates (Nunc 
Maxisorp, flat-bottom) according to the use of HRP-conjugated secondary antibodies. Purified FLAG-
HaloTag protein and EpCAM (Sino Biological Inc.) were serially diluted with PBS buffer. Each protein 
solution was loaded into the wells and incubated at 4 °C overnight to immobilize the target proteins on 
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the surface of the plate through physical adsorption.73 At the next day, each well was washed four times 
with PBS buffer containing 0.1% Tween-20 (PBST). The blocking buffer (5% goat serum in PBST) was 
loaded and incubated with gently shaking for 4 h at RT. After blocking, each well was washed four 
times with PBST and the solutions of diluted primary antibodies against FLAG (anti-FLAG mouse 
IgG1 (Abcam) and anti-FLAG rabbit IgG (Thermo-Fisher)) and EpCAM (anti-EpCAM mouse IgG1 
and anti-EpCAM rabbit IgG (Sino Biological Inc.)) were loaded in the wells of the target analyte 
(FLAG-HaloTag protein or EpCAM)-immobilized plates and incubated with gently shaking for 1 h at 
RT. Each well was washed four times with PBST. Subsequently, corresponding anti-mouse or anti-
rabbit HRP-conjugated secondary antibodies (Jackson ImmunoResearch Inc.) or HRP:Nbs were added 
to wells and incubated with gently shaking for 1 h at RT, and then washed five times with PBST. The 
substrate 3,3',5,5'-tetramethylbenzidine (TMB) solution (Thermo Fisher) was loaded into each well. 
The reaction solutions were incubated for 2 min at RT and 2 N H2SO4 solution was added immediately 
into each well to stop the reaction. The absorbance of each well was monitored at 450 nm with a 
microplate reader, SpectraMAX 190 (Molecular Devices). All the experiments were conducted three 
times independently and plotted with errors. 
 
Cell culture for TSA-based immunohistochemistry  
NIH3T6.7 and A431 cells were cultured in DMEM supplemented with 10% (v/v) FBS and 1% 
antibiotic-antimycotic. MCF-7 cells were cultured in RPMI-1640 supplemented with 5% FBS and 1% 
antibiotic-antimycotic. All cells were incubated in humidified atmosphere of 5% CO2 and 95% air at 37 
ºC. 
 
Preparation and analysis of fluorescence cell microscopy and TSA-based cell immunohistochemistry  
The NIH3T6.7, A431, and MCF-7 cells (1 × 105/well) were grown on microscope cover glass (18 
mm Φ) in 12-well plate (SPL). Cells were fixed with 4% paraformaldehyde in PBS for 20 min at 4 °C 
and washed three times with PBS. To prevent non-specific binding of sample to the background, the 
blocking reagent (5% BSA, 5% FBS, and 0.5% Triton X-100 in PBS) was treated and incubated at room 
temperature for 1 h prior to sample treatment and rinsed with wash buffer (0.1% Triton X-100 in PBS). 
The fixed NIH3T6.7 and A431 cells were treated with diluted anti-HER2 mouse IgG1 and anti-EGFR 
rabbit IgG, respectively, for 2 h at RT. The negative MCF-7 cells were treated in parallel with diluted 
anti-HER2 mouse IgG1 or anti-EGFR rabbit IgG for 2 h at RT.   
For fluorescence cell imaging, Alexa647:MG1Nb and F5M:RNb were incubated with NIH3T6.7 
cells and A431 cells, respectively, for 2 h at RT after washing fixed cell three times with wash buffer. 
The MCF-7 cells were also treated with Alexa:647:MG1Nb or F5M:RNb. Before sealing, the cells were 
washed three times with wash buffer and nuclei were stained with DAPI. Images of samples were 
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obtained by using Olympus Fluoview FV1000 fluorescent microscope (Olympus, UOBC). 
For the TSA assays, the anti-mouse HRP-conjugated secondary antibodies, HRP:MG1Nb, or 
HRP:RNb were incubated with NIH3T6.7 cells pre-incubated with anti-HER2 mouse IgG1 for 2 h at 
RT. The anti-rabbit HRP-conjugated secondary antibodies, HRP:MG1Nb or HRP:RNb were incubated 
with A431 cells pretreated with anti-EGFR rabbit IgG for 2 h at RT. Tyramide working solution was 
freshly prepared by diluting the tyramide stock solution 1:100 in amplification buffer with 0.0015% 
H2O2 just before the reactions and 100 μL was added to each sample. The reaction mixtures were 
incubated at RT for 10 min and rinsed with PBST. The nuclei of the cells were also stained with DAPI. 
Fluorescence cell images were obtained using an Olympus Fluoview FV1000 confocal microscope 
(Olympus, UOBC). 
 
Xenopus embryo sample preparation 
Adult Xenopus laevis female were ovulated by human chorionic gonadotropin (hCG) injection. 
Eggs were in vitro fertilized and dejellied with 3% cysteine in 1/3X MMR (Marc’s Modified Ringers) 
solution (pH 7.9). Fertilized eggs and embryos were grown up in 1/3X MMR. To confirm the function 
of each HRP:MG1Nb or HRP:RNb in TSA-based immunohistochemistry at tissue-based samples, we 
fixed embryos between stage 24 and 26 with MEMFA fixation solution (MEM salts and 4% 
formaldehyde) for 2 h at RT or overnight at 4°C. Then, fixed embryos were used for TSA-based 
immunohistochemistry. 
 
TSA-based immunohistochemistry of whole embryos 
Xenopus embryos were incubated in blocking solution (10% FBS, 2% DMSO in TBS + 0.1% 
Triton X-100) for 30 min at RT to inhibit nonspecific binding before immunohistochemistry. For 
labeling α-tubulin or skeletal muscle fiber, each anti-α-tubulin rabbit IgG (abcam) or anti-skeletal 
muscle fiber mouse IgG1 (12/101, DSHB) were diluted according to manufacturer’s protocol and 
incubated overnight at 4℃. After washing three times, the diluted HRP-conjugated secondary 
antibodies (Sigma-Aldrich) or HRP:Nbs were incubated for 2 h at RT. For the tyramide labeling, all 
embryo samples were incubated with Alexa-488 tyramide or Alexa-647 tyramide in amplification buffer 
according to manufacturer’s protocol to accumulate tyramide solution in tissues for 30 min, then 0.0015% 
of H2O2 was added and incubated additional 30 min for signal amplification. Images were captured 




3.4 Results and Discussion 
Horseradish peroxidase (HRP) is conjugated to SpyCatcher, and IgG-binding nanobodies are 
genetically fused to SpyTag  
Horseradish peroxidase (HRP) is one of the most usually conjugated enzymes with secondary 
antibodies because it is highly stable and produces enough signals in immunoassays for detecting low-
abundance target molecules. We used the SpyTag/SpyCatcher (ST/SC) system to construct HRP-
conjugated IgG-binding nanobodies as signal amplifiers. We selected the SC protein as our scaffold 
protein and substituted the serine residue at position 10 of SC with a cysteine (SCS10C) to conjugate EZ-
Link maleimide activated horseradish peroxidase (Mal-HRP).71 Meanwhile, we prepared two recently 
developed nanobodies, mouse IgG1-binding nanobody (MG1Nb) and rabbit IgG-binding nanobody 
(RNb), and genetically introduced a SpyTag peptide (AHIVMVDAYKPTK) with an extra flexible 
linker to each C-terminus. SCS10C and the SpyTag-fused nanobodies (Nb-STs; MG1Nb-ST and RNb-
ST) were overexpressed in bacteria and purified with one-step Ni-NTA agarose column 
chromatography.49 The purity and apparent molecular mass of SCS10C, MG1Nb-ST, and RNb-ST were 
confirmed with SDS-PAGE (Figure 3.2A). HRP-conjugated SC (HRP-SC) was obtained by reacting 
SCS10C with excess amounts of Mal-HRP, followed by removing the unreacted Mal-HRP and SC (Figure 
3.2B). The majority of HRP conjugated with one SCS10C, and 15 % of HRP conjugated with two SCS10C, 
which corresponds to bands at approximately 65 kDa and 78 kDa, respectively (Figure 3.2C). 
 
    
 
Figure 3.2 Characterization of purified proteins and reaction proteins using SDS-PAGE. (A) SDS-
PAGE analysis of purified SCS10C and Nb-STs (MG1Nb-ST and RNb-ST). (B) SDS-PAGE analysis of 
(3) reaction products obtained from (1) SCS10C and (2) the EZ-Link maleimide-activated horseradish 
peroxidase (Mal-HRP) and reaction products purified with Ni-NTA beads (4) and centrifugal filter (5). 




SpyTag-fused IgG-binding nanobodies (Nb-STs) are ligated with HRP-SC to produce IgG-binding 
signal amplifiers, HRP:MG1Nb and HRP:RNb 
To construct HRP-conjugated IgG-binders, we first optimized the reaction time and ratio of 
MG1Nb-ST or RNb-ST to HRP-SC. We mixed HRP-SC with MG1Nb-ST or RNb-ST at the molar ratio 
of 1:1.5 to use all available HRP-SC. The ligation reaction between the Nb-STs and HRP-SC occurred 
in about 10 min, consuming all the HRP-SC (Figure 3.3) in consistent with previous reports.70, 76 To 
quantify the molar ratios of HRP and nanobody (MG1Nb or RNb) in each HRP:Nb, we acquired the 
absorbances of each HRP:Nb at 280 and 403 nm, indicating the presence of protein and heme, 
respectively, and calculated the molar concentration using the molar extinction coefficients (εmolar) for 
each (Figure 3.4A). The UV/Vis absorption spectra revealed that each MG1Nb-ST or RNb-ST was 
ligated to HRP-SC at 1:1 molecular ratio through an isopeptide bond between the ST and SC (Figure 
3.4B). In addition, each protein’s elution profiles were checked with that of a protein standard mixture 
to confirm whether they form any high ordered oligomers or contain any contaminants (Figure 3.4C).  
These results imply that the cysteine mutation in SC and subsequent HRP conjugation did not disturb 
the ligation reaction and that HRP:MG1Nb and HRP:RNb were successfully established. 
To investigate the binding behaviors of HRP:MG1Nb and HRP:RNb to mouse IgG1 and rabbit 
IgG, respectively, we performed surface plasmon resonance (SPR) analysis (Figure 3.5),73 We first 
immobilized either mouse IgG1 (anti-FLAG mouse IgG1) or rabbit IgG (anti-FLAG rabbit IgG) on the 
surfaces of SPR CM5 chips and then introduced MG1Nb-ST and RNb-ST alone, not ligated to HRP-
SC, to the corresponding mouse IgG1- or rabbit IgG-immobilized CM5 chip. We observed rapid 
increases of SPR response units (RU) upon the introduction of Nb-ST concentrations from 62.5 nM to 
500 nM and slow decreases of RU upon washing with buffers (Figure 3.5A and 3.5C). In contrast, no 
apparent change was observed upon the introduction of MG1Nb-ST (Figure 3.5E) or RNb-ST (Figure 
3.5G) to mismatched rabbit IgG- or mouse IgG1-immobilized CM5 chips, respectively, suggesting that 
there is no detectable cross-binding between them. MG1Nb-ST and RNb-ST exhibited strong binding 
to their corresponding immunoglobulins with dissociation constants (Kd) of 0.37 nM and 2.61 nM, 
respectively (Figure 3.5E). Besides, when HRP:MG1Nb and HRP:RNb were introduced upon ligation 
to the corresponding mouse IgG1- and rabbit IgG-immobilized CM5 chips, they showed high binding 
affinity as well (Figure 3.5B and 3.5D), with dissociation constants (Kd) of 12 nM and 1.77 nM, 
respectively (Figure 3.5E). HRP-SC ligation to nanobodies may have a slight effect on binding behavior 
to antibodies. However, HRP:MG1Nb and HRP:RNb can still selectively and strongly bind to IgGs 







Fig. 3.3 SDS-PAGE analysis of reaction results of HRP-SC and Nb-STs. Reaction results of (A) 
MG1Nb-ST with HRP-SC and (B) RNb-ST with HRP-SC. Reactions were sampled at the indicated 
times, run on SDS-PAGE, and stained with Coomassie blue. Molecular weight markers were run 
together, and the apparent molecular weights are indicated (solid arrow indicates IgG-binding signal 
amplifiers, HRP:MG1Nb and HRP:RNb, respectively). 
 
Figure 3.4 Characterization of purified proteins and reaction proteins using analytical methods. 
(A) UV-vis absorption spectra and (B) molecular concentration ratio of SCS10C, Mal-HRP, HRP:MG1Nb 
and HRP:RNb determined by measuring with UV-vis spectrophotometer. (C) The gel filtration elution 
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profiles of used proteins in this study. All experiments were performed on a Superose 6 column (GE 
Healthcare). The calibration of the gel filtration was used to estimate molecular mass based on the 
protein’s elution volume. The values between brackets indicate the estimated versus the theoretical 




Figure 3.5 SPR sensorgrams of Nb-STs and HRP:Nbs. (A) MG1Nb-ST or (B) HRP:MG1Nb binding 
to mouse IgG1-immobilized CM5 chip (black lines) and (C) RNb-ST or (D) HRP:RNb binding to rabbit 
IgG-immobilized CM5 chip (black lines) and the fitting curves (red lines). (E) MG1Nb-ST or (F) 
HRP:MG1Nb binding to rabbit IgG-immobilized CM5 chip (black lines) and (G) RNb-ST or (H) 
HRP:RNb binding to mouse IgG1-immobilized CM5 chip. The time points at which samples or washing 
buffers are introduced are indicated as black and gray arrows, respectively. (I) The binding parameters 
for the interactions of MG1Nb and mouse IgG1 or RNb and rabbit IgG by SPR analysis (ka; association 





HRP:MG1Nb and HRP:RNb serve as signal amplifiers specific to primary antibodies in western 
blots 
Biological samples contain many proteins with similar size and properties that are not dominant 
enough to be detected with simple fluorescence dye-labeled antibodies or affinity reagents.5, 89 Therefore, 
it is often necessary to quantitatively amplify original signals to detect specific low abundant target 
molecules. Western blot is generally used to detect specific low abundant target proteins in complex 
biological samples and quantify them. We investigated whether HRP:MG1Nb and HRP:RNb can 
selectively bind to target-bound mouse IgG1 or rabbit IgG, respectively, and quantitatively amplify 
signals in western blots. We first performed western blots with purified samples of known concentration 
to examine whether HRP:Nbs can quantitatively amplify original signals according to the 
concentrations applied. We purified FLAG-tag fused HaloTag protein (FLAG-HaloTag), serially diluted 
the protein from 10 to 160 ng, ran the dilutions out in an SDS-PAGE, and transferred them onto the 
polyvinylidene difluoride (PVDF) membrane. After blocking with 5% skimmed milk, membranes were 
probed with either anti-FLAG mouse IgG1 or anti-FLAG rabbit IgG. We then treated the membranes 
with either anti-mouse and anti-rabbit conventional HRP-conjugated secondary antibodies or 
HRP:MG1Nb and HRP:RNb, respectively, and subsequently added enhanced chemiluminescence (ECL) 
western blotting substrate solution. Anti-mouse HRP-conjugated secondary antibody (Figure 3.6A) and 
HRP:MG1Nb (Figure 3.6B) probed with anti-FLAG mouse IgG1 generated similar series of 
concentration-dependent signals for purified FLAG-HaloTag without significant background noise 
(Figure 3.6A and 3.6B). The signal intensities gradually increased as the concentrations of FLAG-
HaloTag increased. Almost identical results were also obtained with anti-rabbit HRP-conjugated 
secondary antibody (Figure 3.6C) and HRP:RNb (Figure 3.6D) when FLAG-HaloTag was probed with 
anti-FLAG rabbit IgG (Figure 3.6C and 3.6D). For quantitative analysis, band intensity was plotted 
against protein input concentration using ImageJ program (Figure 3.7). Both HRP:MG1Nb and 
HRP:RNb showed linear signal enhancement patterns correlating with the sample concentrations and 
generated signal intensities at each concentration highly similar to those of conventional HRP-
conjugated secondary antibodies (Figure 3.7A and 3.7B). 
Western blot can quantitatively detect target molecules in complex biological samples. We next 
performed western blots with lysates from HEK293T cells, which were transiently transfected with 
FLAG-HaloTag genes. A serial dilutes of cell lysates (0.65 to 10 μg in total protein concentration) were 
applied to SDS-PAGE. The samples transferred to a PVDF membrane, processed as a western blot, and 
probed as described above. Both anti-mouse HRP-conjugated secondary antibody (Figure 3.6E) and 
HRP:MG1Nb (Figure 3.6F) probed with anti-FLAG mouse IgG1 successfully amplified the series of 
concentration-dependent signals of cell lysates at the expected locations without significant background 
(Figure 3.6E and 3.6F). Similar results were obtained with anti-rabbit HRP-conjugated secondary 
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antibody (Figure 3.6G) and HRP:RNb (Figure 3.6H) in combination with anti-FLAG rabbit IgG (Figure 
3.6G and 3.6H). Besides, there was no band signal generated with HRP:MG1Nb and HRP:RNb when 
anti-FLAG rabbit IgG and anti-FLAG mouse IgG1 were used as primary antibodies, respectively, 
(Figure 3.6B, 3.6D, 3.6F, and 3.6H), confirming that there is no detectable cross-binding reactivity in 
consistence with SPR data. HRP:MG1Nb and HRP:RNb exhibited linear signal amplification patterns 
dependent on target molecule concentration in a complex cell lysate, and the HRP:Nb patterns 
corresponded well to those of conventional HRP-conjugated secondary antibodies (Figure 3.7C and 
3.7D). These results indicate that HRP:MG1Nb and HRP:RNb can specifically recognize target-bound 
mouse IgG1 and rabbit IgG, respectively, without cross-reaction and quantitatively amplify the signals 
of target analytes in western blots effectively. These HRP:Nbs present an opportunity to substitute 
conventional HRP-conjugated secondary antibodies with recombinant signal amplifiers.  
 
     
 
Figure 3.6 Western blots. Various concentrations of (A–D) purified FLAG-HaloTag proteins and (E–
H) FLAG-HaloTag gene-transfected cell lysates were loaded on SDS-PAGE, transferred to a membrane, 
and probed with either anti-FLAG mouse IgG1 or anti-FLAG rabbit IgG. Next, membranes were treated 
with (A, E) anti-mouse HRP-conjugated secondary antibody and (B, F) HRP:MG1Nb or anti-rabbit 
HRP-conjugated secondary antibody and (D, H) HRP:RNb, respectively. All bands were developed 






Figure 3.7 Quantitative analyses of signal enhancement of western blots. Band signal intensities of (A 
and B) purified FLAG-HaloTag proteins and (C and D) FLAG-HaloTag gene-transfected cell lysates 
were probed with (A and C) anti-FLAG mouse IgG1 and treated with anti-mouse HRP-conjugated 
secondary antibody and HRP:MG1Nb or probed with (B and D) anti-FLAG rabbit IgG and treated with 





HRP:MG1Nb and HRP:RNb are utilized as primary antibody-specific, but target analyte-
independent signal-amplifiers in indirect ELISA 
To investigate the application of HRP:Nbs in another immunoassay, we performed indirect ELISA 
to detect target analytes present in a solid surface using antibodies. First, via physical adsorption, we 
immobilized various concentrations of the previously mentioned purified FLAG-HaloTag protein as a 
model protein on the surface of an ELISA plate, followed by treatment with blocking buffer. We applied 
either anti-FLAG mouse IgG1 or anti-FLAG rabbit IgG to the immobilized FLAG-HaloTag. After 
extensive washing, we loaded the corresponding HRP-conjugated secondary antibodies or HRP:Nbs. 
Next, we added tetramethylbenzidine (TMB) substrate solution onto the plates and measured the 
absorption at 450 nm. When we applied anti-FLAG mouse IgG1 with anti-mouse HRP-conjugated 
secondary antibody and HRP:MG1Nb as signal amplifiers, we obtained similar representative 
sigmoidal curves for each HRP construct between the linear absorbance range of 2 to 125 nM for the 
FLAG-HaloTag proteins (Figure 3.8A). We also obtained comparable sigmoidal curves between the 
linear absorbance range of 0.488 to 125 nM using anti-rabbit HRP-conjugated secondary antibody and 
HRP:RNb in combination with anti-FLAG rabbit IgG (Figure 3.8B). To demonstrate target analyte 
independency, we performed the same assay with another target biomolecule, epithelial cell adhesion 
molecule (EpCAM), a biomarker for circulating tumor cells.90 EpCAM showed almost identical 
sigmoidal detection curves to both HRP:Nbs and HRP-conjugated secondary antibodies (Figure 3.8C 
and 3.8D) with about the same linear response range. These data suggest that HRP:MG1Nb and 
HRP:RNb can individually recognize and bind to their corresponding target-bound primary antibodies 
in indirect ELISA. The HRP:Nbs can target independently and amplify signals comparably to 





Figure 3.8 Indirect ELISA. Various concentrations of (A and B) purified FLAG-HaloTag proteins and 
EpCAM (C and D) were immobilized on 96 well plates and probed with either (A and C) anti-FLAG 
mouse IgG1 or (B and D) anti-FLAG rabbit IgG to capture target molecules. Next, plates were treated 
with (A and C) anti-mouse HRP-conjugated secondary antibody and HRP:MG1Nb or (B and D) anti-
rabbit HRP-conjugated secondary antibody and HRP:RNb with the TMB substrate solution for signal 
enhancement. Signal responses were plotted and linear signal responses were observed at medium 





Simultaneous HRP:MG1Nb and HRP:RNb enhance fluorescence signal intensities of two different 
target molecules in cell-based TSA assays 
The tyramide signal amplification (TSA) assay is an antibody-based proximity labeling assay that 
provides enhanced sensitivity in cell and tissue applications.15, 91 Upon binding to target-bound primary 
antibodies, HRP-conjugated secondary antibodies locally activate fluorescent dye-conjugated tyramide 
derivatives to label adjacent localized proteins, resulting in the significant enhancement of the 
fluorescence signal. In this study, we examined if HRP:Nbs activates the fluorescent dye-conjugated 
tyramide derivatives in a TSA assay to enhance the fluorescent signal at a target site. 
To directly compare fluorescent signals generated by a single fluorescent dye to TSA, we conjugated 
SCS10C with Alexa Fluor 647 maleimide or fluorescein-5-maleimide (Alexa647-SC or F5M-SC) via 
thiol-maleimide Michael-type addition. After removing unreacted dyes, Alexa647-SC and F5M-SC 
were mixed with excess amounts of MG1Nb-ST and RNb-ST to form Alexa647:MG1Nb (Figure 3.9A) 
and F5M:RNb (Figure 3.9B), respectively, and free Nb-ST was removed using a centrifugal filter. 
HER2-overexpressing NIH3T6.7 cells and EGFR-overexpressing A431 cells were prepared and 
initially imaged with Alexa647:MG1Nb and F5M:RNb in combination with anti-HER2 mouse IgG1 
and anti-EGFR rabbit IgG, respectively. Relatively weak red and green fluorescence signals appeared 
in Alexa647:MG1Nb-treated NIH3T6.7 cells with anti-HER2 mouse IgG1 (Figure 3.10A, top panel) 
and F5M:RNb-treated A431 cells with anti-EGFR rabbit IgG, respectively (Figure 3.10B, top panel). 
In contrast, neither of the dye-conjugated antibody-binding nanobodies bound to MCF-7 cells, which 
do not overexpress HER2 or EGFR (Figure 3.11A and 3.11E). For TSA, we employed same cell 
line/primary antibody pairs with conventional HRP-conjugated secondary antibodies or HRP:Nbs 
instead of dye-conjugated nanobodies and further treated them with a TSA reagent (a mixture Alexa 
647 tyramide and 0.0015 % of H2O2) for 10 min. When anti-mouse HRP-conjugated secondary antibody 
and HRP:MG1Nb were selectively bound to target NIH3T6.7 cells via anti-HER2 mouse IgG1, the 
fluorescence microscopic images revealed extremely high red fluorescence signals (Figure 3.10A, 
second and third panels, respectively). Use of HRP:RNb in place of HRP:MG1Nb did not generate any 
fluorescence signal (Figure 3.10A, bottom panel). Similarly, dramatically enhanced green fluorescence 
signals were observed in anti-rabbit HRP-conjugated secondary antibody or HRP:RNb-treated A431 
cells with Alexa 488-conjugated tyrimide (Figure 3.10B, second and bottom panels, respectively), and 
use of HRP:MG1Nb in place of HRP:RNb did not produce any fluorescence signals (Figure 3.10B, 
third panel). Fluorescence signal intensity plots revealed that TSA with HRP-conjugated secondary 
antibody or HRP:Nbs generated 5 times more fluorescence signal than that of fluorescently labeled 
antibodies (Figure 3.10C and 3.10D). Also, HRP:Nbs showed enhanced signal with comparable 
sensitivity to that of conventional secondary antibodies. We also confirmed that there was no 
fluorescence signal generated in similarly treated HER2 and EGFR double negative MCF-7 cells 
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(Figure 3.11), suggesting minimal apparent non-specific binding of HRP-conjugated secondary 
antibody or HRP:Nbs to the cells. 
In addition to pre-existing surface markers, we presented target proteins on the surface of the cells 
by transiently transfecting HEK293T cells with the FLAG-HaloTag gene, which translates as an integral 
membrane protein that presents FLAG-tag on the plasma membrane. We then selectively imaged these 
cells with TSA. We first treated the transfected HEK293T cells with Oregon green 488-HaloTag ligands 
to confirm the expression of FLAG-HaloTag proteins on the surface of the HEK293T cells. We further 
incubated the cells with anti-FLAG mouse IgG1 or anti-FLAG rabbit IgG and processed them with the 
corresponding HRP-conjugated secondary antibodies or HRP:Nbs, along with TSA reagents (a mixture 
Alexa 647 tyramide and 0.0015 % of H2O2) as described above. The fluorescence signals of Oregon 
green 488 and Alexa 647 overlapped, indicating that only the transiently transfected cells were 
selectively detected, and their signals are amplified (Figure 3.12). 
Because HRP:MG1Nb and HRP:RNb selectively bind without cross-reaction to mouse IgG1 and 
rabbit IgG, respectively, it is possible for them to be used simultaneously to detect two different target 
molecules in a sample using two different primary antibodies. To demonstrate the simultaneous 
detection of two different targets in the same sample with HRP:MG1Nb and HRP:RNb, we selected 
two different target proteins (α-tubulin and EGFR) in A431 cells and treated the cells with both anti-α-
tubulin mouse IgG1 and anti-EGFR rabbit IgG. To avoid the cross-catalytic activity of previously bound 
HRP-conjugated secondary antibody or HRP:Nb, we performed the TSA assays sequentially. First, we 
treated them with either HRP-conjugated anti-mouse IgG1 antibody or HRP:MG1Nb, followed by 
incubation in an Alexa 647 tyramide and 0.0015% H2O2 mixture for 10 min to amplify specific signals 
of α-tubulin. Next, we inactivated the previously associated HRPs with 3% H2O2. Further, we treated 
the cells again with either HRP-conjugated anti-rabbit IgG antibody or HRP:RNb, followed by 
incubation in an Alexa 488 tyramide and 0.0015% H2O2 mixture for 10 min to amplify specific signals 
of EGFR. In both the HRP-conjugated secondary antibody-treated and HRP:Nb-treated A431 cells, α-
tubulin and EGFR were individually visualized with red and green colors, respectively, in single cells 
(Figure 3.10E and 3.10G). A fluorescence intensity correlation using line scan analysis in microscopy 
was performed to characterize the degree of overlap between two channels in an image (α-tubulin-red 
and EGFR-green channels). The merged images and plots showed no significant overlap of α-tubulin 
and EGFR, located in cell cytosol and surface, respectively (Figure 3.10F and 3.10H). These data 
indicate that HRP:Nbs can bind species-specifically to target-bound primary antibodies and perform 






Figure 3.9 SDS-PAGE analysis of reaction results of dye conjugated SCs and Nb-STs. Reaction 
results of (A) MG1Nb-ST with Alexa647-SC and (B) RNb-ST with F5M-SC. Reactions were sampled 
at the indicated times, run on SDS-PAGE, stained with Coomassie blue, and imaged them with white 
light (left panels) and fluorescence (right panels). Molecular weight markers were run together, and the 
apparent molecular weights are indicated (solid arrow indicates fluorescent dye conjugated nanobodies, 








Figure 3.10 Fluorescent cell imaging and tyramide signal amplification (TSA) assays. (A) HER2 
overexpressing NIH3T6.7 cells and (B) EGFR overexpressing A431 cells were probed with anti-HER2 
mouse IgG1 and anti-EGFR rabbit IgG, respectively, and subsequently incubated with (A, top panels) 
Alexa647:MG1Nb or (B, top panels) F5M:RNb, or treated with (second panels) HRP-conjugated 
secondary antibodies, (third panels) HRP:MG1Nb, or (bottom panels) HRP:RNb in the presence of TSA 
reagent. Relative fluorescence intensity of dye-conjugated and TSA resultants in (C) NIH3T6.7 cells 
and (D) A431 cells were plotted. (E and G) A431 cells were probed with anti-α-tubulin mouse IgG1 
and anti-EGFR rabbit IgG, simultaneously, and then incubated with (E) anti-mouse HRP-conjugated 
secondary antibody or (G) HRP:MG1Nb. Subsequently, previously bound signal amplifiers were 
inactivated with 3% H2O2 and (E) anti-rabbit HRP-conjugated secondary antibody or (G) HRP:RNb 
were then added. The fluorescence intensity correlations generated by (F) HRP-conjugated secondary 




Figure 3.11 Tyramide signal amplification (TSA) assays with negative cells. HER2 and EGFR 
double negative MCF-7 cells were probed with (A – D) anti-HER2 mouse IgG1 and (E – H) anti-EGFR 
rabbit IgG, respectively, and subsequently incubated with (A) Alexa647-conjugated MG1Nb and (E) 
F5M-conjugated RNb, (B, F) HRP-conjugated secondary antibodies, (C, G) HRP:MG1Nb, or (D, H) 
HRP:RNb. For signal amplification, TSA reagents (Alexa 647 and Alexa 488 tyramides) were treated 




Figure 3.12 Tyramide signal amplification (TSA) assays in FLAG-HaloTag gene-transfected 
HEK293T cells. Transfected HEK293T cells were treated with HaloTag Oregon Green Ligands to 
confirm the expression of FLAG-HaloTag on the surface of cells, then probed with (A and B) anti-
FLAG mouse IgG1 and (C and D) anti-FLAG rabbit IgG, respectively. For signal amplification, they 
were subsequently incubated with (A) anti-mouse HRP-conjugated secondary antibody, (B) 
HRP:MG1Nb, (C) anti-rabbit HRP-conjugated secondary antibody or (D) HRP:RNb in presence of 





HRP:MG1Nb and HRP:RNb efficiently penetrate Xenopus whole embryos and successfully amplify 
target protein signal in TSA assays 
To investigate whether HRP:Nbs can be used in more complex and heterogeneous tissue TSA assays, 
we prepared Xenopus laevis whole embryos and performed TSA-based immunostaining with 
HRP:Nbs.92, 93 We tested several tissue-specific primary antibodies such as anti-skeletal muscle fiber 
mouse IgG1 (12/101) 94 and anti-α-tubulin rabbit IgG to visualize the muscle and the cilia, respectively, 
and then incubated the samples with either HRP-conjugated secondary antibodies or HRP:Nbs followed 
by a TSA assay. The fluorescence imaging analysis revealed that the HRP-conjugated secondary 
antibody and HRP:Nb selectively bound to the primary antibody (Figure 3.13A; top and middle panels, 
3.13B; top and bottom panels), resulting in high target-specific signal amplification for whole embryo 
samples, whereas mismatched HRP:Nbs did not (Figure 3.13A; bottom panel, 3.13B; middle panel). 
These data imply that HRP:Nbs can efficiently penetrate tissue samples and selectively bind to the 
target-bound primary antibodies, resulting in high target-specific signal amplification. To demonstrate 
simultaneous detections of two different target molecules in the same sample with HRP:MG1Nb and 
HRP:RNb, we labeled two different targets (skeletal muscle fiber and α-tubulin) in the same whole 
embryo mount sample (Figure 3.13C and 3.13D). We treated the sample with two different primary 
antibodies as described above. Next, we performed a TSA assay with either HRP-conjugated secondary 
antibodies (Figure 3.13C) or HRP:Nbs (Figure 3.13D), which resulted in target-specific dual-color 
labeling. These data suggest that HRP:Nbs can be applied as dual-labeling reagents in localization 
studies of multiple target proteins combined with primary mouse and rabbit IgGs, even in thick and 





Figure 3.13 Tyramide signal amplification (TSA) assays in Xenopus whole embryos. Xenopus 
samples were probed with (A) anti-skeletal muscle fiber mouse IgG1 and (B) anti-α-tubulin rabbit IgG 
and then incubated with HRP-conjugated secondary antibodies (top panel), HRP:MG1Nb (middle panel) 
or HRP:RNb (bottom panel) in the presence of TSA reagents. (C and D) Samples were probed with 
anti-skeletal muscle fiber mouse IgG1 and anti-α-tubulin rabbit IgG, simultaneously, and then incubated 
with (C) anti-mouse HRP-conjugated secondary antibody or (D) HRP:MG1Nb in the presence of TSA 
reagents. After inactivation of previously bound HRP, (C) anti-rabbit HRP-conjugated secondary 
antibody or (D) HRP:RNb were added with fresh TSA reagent. Scale bars: 50 μm (whole embryos 




Here we established plug-and-playable HRP-conjugated recombinant IgG-binding signal 
enhancers with an excellent high binding affinity for mouse IgG1 and rabbit IgG, respectively, based 
on ST/SC protein ligation system. HRP was conjugated to an SC scaffold protein via a thiol-maleimide 
reaction, whereas two species-specific mouse IgG1-binding (MG1Nb) and rabbit IgG-binding 
nanobodies (RNb) were genetically fused to an ST peptide. The HRP-conjugated SCs were ligated to 
the individual ST-fused nanobodies, via a covalent isopeptide formation between ST and SC in a plug-
and-playable manner, and we performed various types of immunoassays to verify their species-specific 
IgG-binding and signal amplification capabilities. In western blots and ELISA, both HRP-conjugated 
nanobodies (HRP:Nbs) specifically recognized target-bound mouse IgG1 and rabbit IgG, respectively, 
without detectable cross-reactivity. We obtained linear signal enhancement patterns correlating to the 
sample concentrations with HRP:Nbs using purified and complex cell lysate samples. HRP:Nbs 
generated signal intensities depending on each concentration, which is comparable to those of 
conventional HRP-conjugated secondary antibodies. They had species-specificity toward their 
corresponding IgGs and were applied for the simultaneous detection and visualization of two different 
target molecules within a single cell in TSA-based immunohistochemistry. Furthermore, HRP:Nbs 
penetrated the thick and complicated whole embryos as well as conventional HRP-conjugated 
secondary antibodies and could selectively label two different target molecules in a single whole embryo 
mount sample, allowing localization studies of multiple target proteins in a single cell or embryo. 
Although secondary antibodies possess very high specificity and affinity to primary antibodies, the 
production of secondary antibodies comes with high manufacturing costs and long preparation time due 
to live animals or mammalian cell culture systems. In contrast, IgG-binding nanobodies, inexpensively 
produced in large quantities in E. coli, do not require live animal production and can be conjugated to 
enzymes via the ST/SC system in a plug-and-playable manner. The recombinant signal-amplifying IgG-
binders we have developed in this study may be reliable alternatives to conventional secondary 




Chapter 4. Concluding Remarks 
 
4.1 Summary and Conclusions 
As stated in Chapter 1, I explained why qualitative and quantitative analyses of target biomolecules 
are important in cells. I then discussed various types of detecting tools in current research for 
visualization or quantitation of target biomolecules with several advantages and disadvantages. To apply 
functional proteins, functional proteins were suggested, and their background information was 
described. 
 
My doctoral research thesis is to develop target-specific labeling nanoplatforms based on 
functional proteins for application in fluorescence cell imaging and immunoassay. 
 
In Chapter 2, I developed a tunable dual-functional (targeting and probing or two different 
targetings) Encap probes using bacterial glue, the ST/SC protein ligation system. I demonstrated its 
target-specific imaging capability with multiple combinations of targeting ligands and colors. I have 
prepared three types of tunable dual-functional Encap protein cage nanoparticles. Polyvalent affibody-
conjugated Encap probes effectively recognize their target cancer cells visualizing specific target cancer 
cells. Dual functional Encap probes targeted and visualized their target cancer cells with multiple 
combinations between desired targeting ligands and desired colors. Besides, dual targeting Encap 
probes visualized two target cells individually without using a set of individual probes. This study 
suggests that the polyvalent nature of Encap allows us to display multiple functional proteins efficiently, 
and ST/SC bacterial glue makes it possible to post-translationally display the desired functional proteins 
in a mixing-and-matching manner on demand. 
 
Lastly, in Chapter 3, I developed a target-specific signal enhancer to be applied in various 
immunoassays. HRP was conjugated to two different recombinant IgG binding nanobodies, respectively, 
using ST/SC protein ligation system, and their excellent high binding affinity was demonstrated. In 
western blots and ELISA, HRP conjugated nanobodies specifically recognized target-bound primary 
antibodies without cross-reactivity and exhibited linear signal amplification patterns correlating to the 
sample concentrations. Their species-specificity toward primary antibody allowed the simultaneous 
detection and visualization of two different target molecules within a single sample derived from cells 
and whole embryos. This study suggests that recombinant signal-amplifying IgG-binders perform as 
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가장 먼저, 지난 5 년 6 개월 간 박사 과정을 무탈하게 마칠 수 있게 많은 도움 주신 강세병 교수님께 
진심으로 감사합니다. 교수님의 뜻 깊은 조언으로 의미 있는 성과를 낼 수 있었습니다. 또한, 바쁘신 와중에 
1, 2 차 committee meeting 과 최종 논문 심사를 위해 시간 내주시고 많은 코멘트 주신 박태주 교수님, 박찬영 
교수님, 채영찬 교수님, 박종남 교수님께 진심으로 감사드립니다.  
 
함께 동거 동락한 실험실 멤버들에게도 감사의 인사를 전합니다. 먼저, 졸업하신 선배님들이 닦아 놓은 
길 위에서 편하게 연구할 수 있어서 감사합니다. 그리고 오랫동안 함께 했던 선배인 김한솔 박사님! 우리 
실험실 분위기 메이커로서, 모두들 즐겁게 잘 지낼 수 있게 도움 주셔서 감사합니다. 미국에 가서 많은 
경험과 실적 쌓아서 돌아오길 바랍니다. 대학원 동기인 최혁준 오빠! 연구 분야는 달랐지만, 필요할 때 
코멘트 잘 해줘서 감사합니다. 차기 랩장으로서, 실험실 잘 이끌어가고 마지막까지 정리 잘해서 졸업 잘하길 
바랍니다. 그리고, 너무 엉뚱해서 당황스럽지만 이제는 어느정도 인간미가 보이는 박성국! 논문 빨리 내고 
졸업 잘해서 시골 촌동네를 벗어나길 바랍니다. 엄살 잘 부리는 찡찡이 엄수민! 남은 기간동안 잘 버티고 잘 
헤쳐 나가서 원하는 사이언스 저널에 논문을 내도록 노력하십시오. 좋은 성과로 졸업하길 기원합니다.  
그리고 우리 실험실에서 유일하게 외향적인 전희진! 소심하고 모자란 오빠들을 데리고 즐거운 실험실 
생활이 될 수 있도록 기원하고 좋은 성과로 졸업하길 바랍니다. 그 동안 모두들 저의 잔소리를 잘 들어줘서 
감사합니다. 모든 것들이 연구하는데 큰 도움이 되길 바랍니다. 필요한 것들이 있으면 언제든지 
연락하십시오. 
 
또한, 힘들지만 즐겁게 인생을 살아가는 우리 가족에게 감사드립니다. 항상 인생을 긍정적으로 바라볼 
수 있도록 많은 사랑 주신 부모님께 감사합니다. 앞으로 받은 만큼 베풀 수 있는 사람이 되도록 
노력하겠습니다. 하나 밖에 없는 여동생 윤현아, 나이 차이는 많이 나지만 오히려 언니처럼 든든하게 옆에 
있어줘서 많은 의지가 되었다. 앞으로 하고 싶은 일 하면서 즐겁게 살길 바란다. 우리집 막내 한경아, 
즐겁게 공부하고 원하는 꿈을 이룰 수 있길 바란다.   
 
마지막으로, 11 년이라는 긴 기간 동안 제 옆을 지켜준 경룡이에게 감사드립니다. 제가 항상 의지할 수 
있고 마음 편하게 연구할 수 있는 데 큰 힘이 되어 주어서 고마워. 앞으로 즐거운 인생 함께 살아가도록 
노력하자.  
 
   이 외에도 제가 살아오는 동안 크고 작은 도움을 주신 모든 분들께 감사드리며, 모두들 행복한 인생을 
살아가길 바랍니다.  
 2020.11.25 
배윤지 드림 


















A. Microperoxidase study 
 
A.1 Introduction 
Microperoxidases are introduced as one of the signal-generating enzymes. Microperoxidase is 
biosynthetic heme-peptide conjugates employed as models for heme protein active sites and catalysts 
and for charge-transfer chromophores with potential applications biosensors and electron carriers.1, 2 
Heme is covalently attached to the peptide via thioether bonds to two cysteine residues within a Cys-
X-X-Cys-His (CXXCH) motif. Microperoxidases with different amino acid sequences are derived from 
various organisms containing cytochrome c and produced by proteolytic digestion.3, 4 The E.coli 
cytochrome c maturation (Ccm) proteins are required to attach the heme to CXXCH motif.5, 6 Heme and 
the apoprotein are synthesized in the E. coli cytoplasm, and both are translocated to the periplasm, 
where the protein’s signal sequence is cleaved.7 The resulting proteins have heme (Figure A1). For 
further study, microperoxidase fusion proteins were established and purified to be applied in enzyme-
mediated signal enhancement.  
 
Figure A1. Schematic representation of the heme attachment process mediated by the Ccm system 
 
A.2 Purification of microperoxidase fusion proteins 
Microperoxidase was fused to SpyCatcher (MP-SC), and its activity was validated through an 
enzyme activity test. MP-SC was inserted into the pETDuet plasmid with an additional signal sequence, 
which is essential for translocation to the periplasm.8 Initially, as a proof of concept, the pETDuet 
plasmid encoding holo MP-SC with or without signal sequence was co-transformed with or without 
pEC86 vector encoding the E.Coli cytochrome c maturation genes CcmABCDEFGH (Figure A2). All 
constructs had HisTag at the C-terminus of MP-SC for purification. They were well overexpressed and 
purified at a high concentration using Ni-NTA chromatography.9 When MP-SCs were overexpressed 
together with pEC86 vector and signal sequence, they only showed a dark red colored pellet. As 
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expected, both signal sequence and CcmABCDEFGH are essential for heme maturation to CXXCH 
motif. 
 
Figure A2. Expression test of microperoxidase fusion proteins 
 
A.3 Characterization of microperoxidase fusion proteins 
The mass value of purified proteins was determined by mass spectrometry. Two mass values were 
detected – heme incorporated or not incorporated MP-SC (Figure A3a). Next, heme incorporation ratios 
were confirmed using UV/vis spectroscopy (Figure A3b). The absorbance of heme shows a maximum 
at 404 nm. The absorbances were detected and calculated at 280 nm and 404 nm to confirm how much 
heme binds to MP-SC using the respective extinction coefficient. 16 % of the total purified MP-SC 
contains heme. Therefore, pure heme attached MP-SC should be purified using several purification 
methods. 
 
Figure A3. Characterization of microperoxidase-SpyCatcher 
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A.4 Catalytic activity of microperoxidase fusion proteins.   
The catalytic activity of MP-SC was compared to that of HRP in a concentration dependent manner. 
The concentration of the enzyme was determined as heme concentration using UV/vis spectroscopy. 
TMB substrates were loaded in an enzyme-loaded plate. After 1 min, the absorbance was measured at 
450nm using a plate reader. MP-SC showed 1000 times lower activity than HRP. 
  
 




















B. Target-specific Labeling Tools to Detect Intracellular Proteins 
B.1 Introduction 
The selective detection of intracellular target proteins is important but challenging, and their 
microscopic visualization has become a powerful tool to understand molecular and cellular processes. 
First, target proteins can be detected by fusing protein domains that can generate fluorescence or 
luminescence as fluorescent reporters. However, large structured tags such as fluorescent proteins, GFP 
can affect the location and function of the tagged proteins.10 An alternative method of visualizing 
proteins in cells is to use target-specific fluorescent probes by combining fluorescent molecules with 
targeting ligands, including antibodies, targeting peptides, or affibody molecules.11 Epitope tags, short 
peptides that can be recognized by targeting ligands, such as antibodies, are widely used in fluorescent 
labeling for microscopy analysis, especially in numerous cases where high-quality antibodies are 
directed against the target protein are unavailable. High specificity and efficiency of fluorescent probes 
against epitope tags are essential for successful detection and visualization of target proteins. The 
FLAG®-, myc- and HA-tags have often been used for immunostainings. Still, due to the large size of 
the antibodies used as binders, they are suboptimal for super-resolution microscopy and exceedingly 
difficult to express within cells. Besides, self-labeling enzymes can be genetically fused with target 
proteins for labeling such as HaloTag, SNAP-tag, and BL tag.12 They can form covalent linkages to 
exogenously added fluorescent ligand and allow microscopic investigations of the labeled fusion 
proteins. In this case, we should change suitable ligand according to the system to be applied. Also, the 
size of these tags can cause resolution problems in super-resolution microscopy.  
To solve these limitations, we introduced SpyTag/SpyCatcher (ST/SC) protein ligation system, 
which was used to label target protein site-specifically in cells. SpyTag peptide and SpyCatcher protein 
recognize each other and form the covalent isopeptide bond with high affinity.13, 14 SpyTag can be fused 
to a target protein with minimal risk of disrupting target function. SpyCatcher can be modified to be 
chemically conjugated with fluorophore by adding active amino acid such as cysteine.13 SpyTagged 
target proteins were recognized by fluorophore-conjugated SpyCatcher and detected by fluorescent cell 
imaging, in the cytoplasm and the organelle lumen, respectively. In this study, site-specific labeling 





B.2 Results and Discussion 
Various proteins in subcellular organelles are labeled by SpyTag/SpyCatcher. 
To examine whether SC could be ligated to ST in the cell, we utilized SC as a scaffold protein and 
substituted serine residue at position 10 of SC with cysteine (SCS10C) to a conjugate fluorescent dye. 
SCS10C was overexpressed in bacteria and purified with simple one-step Ni-NTA agarose column 
chromatography. Purified SCS10C was conjugated with fluorescein-5-maleimide (F5M-SC) or Alexa 
Fluor 647 maleimide (Alexa647-SC) via thiol-maleimide Michael-type addition. To quantify the molar 
ratio of the SC and fluorescent dyes (F5M or Alexa647) in dye conjugated-SC, we obtained the 
absorbance of dye conjugated-SC at 280 nm and 494 or 594 nm that indicated the presence of protein 
and fluorophore, respectively, and calculated molar concentration. UV/Vis absorption spectra showed 
this labeling ratio is 1:1 ratio, which ensures one cysteine is labeled by a maleimide activated dye (Fig. 
S1). ST is a small peptide and has minimal risk of disrupting the function of target, so it was genetically 
inserted to a portion of the extracellular surface with HaloTag, which has its fluorescence ligand and is 
used as a marker of protein expression. SpyTag-HaloTag fusion protein (ST-HT-TM) was transiently 
expressed at the cell membrane in HEK293T cells, pre-incubated with 10 μM F5M-SC for 45 min, co-
treated with 5 μM permeant HaloTag ligand TMR for 15 min, washed and imaged. Confocal images 
show that only cells labeled with red TMR ligand are labeled with F5M-SC binding to the cell 
membrane-localized ST in live cells, with minimal background (Figure B1a). Permeant HaloTag ligand 
TMR labeled cytosolic ST, which failed to move from the cytosol to the cell surface, whereas F5M-SC 
labeled the cell membrane-localized ST specifically. Almost identical results were obtained with F5M-
SC bound to the cell membrane-localized ST in permeabilized cells (Figure B1a). Ligation of ST/SC 
was confirmed by western blot using cell lysate. F5M-SC ligated with ST both in the live cell surface 
before lysis and in the supernatant after lysis (Figure B2a). These data showed that dye conjugated SC 
could specifically label SpyTagged cell membrane-localized proteins in permeabilized or live cells. To 
demonstrate that the ST/SC system had sufficient efficiency in detecting intracellular proteins, ST-HT 
was transiently expressed in cytosol, nucleus, mitochondria. We first tested whether dye conjugated SC 
can label intracellularly expressed ST in live cells. As expected, F5M-SC or Alexa647-SC did not label 
the inaccessible intracellular ST, whereas permeant HaloTag ligand TMR or Oregon green 488 ligand 
could label intracellularly expressed HaloTag in live cells (Figure B1b-B1d). However, when cells were 
permeabilized, F5M-SC or Alexa647-SC was able to label the intracellularly expressed ST (Figure B1b-
B1d). Ligation of ST/SC was confirmed by western blot using cell lysate. F5M-SC and Alexa647-SC 
did not ligate intracellular ST in live cells, but they ligated ST in the supernatant after lysis (Figure B2b-
B2d). These data showed that dye conjugated SC could label SpyTagged intracellularly localized 




Figure B1. Schematic representation of target-specific labeling tools 
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